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ABSTRACT
IDENTIFICATION OF SUPPRESSORS OF sptlO THAT AFFECT ADH2 
EXPRESSION IN THE YEAST SACCHAROMYCES CEREVISIAE
by
Bradley D. Anderson 
University of New Hampshire, September, 2001
Suppression of the effects of an sptlO  mutation on ADH2 expression is a 
phenotype shared by a small number of genes involved in the regulation of gene 
expression. All six known suppressors of sptlO are either components of the CCR4-NOT 
Complex (CCR4, C AFl,NO T4), or have been shown to interact with the complex 
CDBF2, SRB9, SRB10). This indicated that sptlO suppression may be characteristic of 
CCR4- like gene regulation. In this work, I conducted a screen for additional suppressors 
of sptlO  at ADH2. The screen identified no less than ten complementation groups, 
including ADH2 and two known suppressors of sptlO, CCR4 and CAFL Further analysis 
identified three previously unidentified suppressors of sptlO, ASG2/EBSI, ASG3ILSM6, 
and ASG6/NUP159. Each of these genes is proposed to affect ADH2 expression at a step 
subsequent to transcriptional initiation, namely mRNA degradation. Along with the 
recent identification of CCR4 and CAF1 as key components of the major yeast
ix
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deadenylase, this research shows that there are important regulatory factors at multiple 
points of mRNA degradation which are important for understanding the complete 
regulation of ADH2 expression and overall gene expression.
x
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CHAPTER I
INTRODUCTION
In the yeast Saccharomyces cerevisiae, alcohol dehydrogenase (ADH) enzymes 
play an important role in metabolism. The pyruvate that results from glycolysis is 
converted into acetaldehyde, and ADH enzymes catalyze the conversion between 
acetaldehyde and ethanol. When metabolizing nonfermentative carbon sources such as 
ethanol, this process is reversed and pyruvate is converted into Acetyl-CoA, which enters 
the tricarboxyllic acid (TCA) cycle. There are two main genes encoding ADH enzymes 
in yeast, ADHl and ADH2.
When yeast are grown in glucose, expression of the AD H l gene is very high, 
while expression at the ADH2 locus is tightly repressed, as no ADH2 mRNA can be 
detected [Futcher et al., 1999]. Upon exhaustion of glucose, the resulting ethanol in the 
media is used as a primary carbon source. Two studies on ADHl expression in ethanol 
media have yielded differing results. One shows AD H l expression to be essentially 
constitutive, while the other noted a 6-10 fold reduction in ADHl mRNA [Futcher et al., 
1999; Denis et al., 1983]. Both studies, however, noticed good correlation between 
mRNA levels and Adhlp levels in the cell. In contrast, Adh2p levels and ADH2 mRNA 
levels increase dramatically in ethanol media as a result of release from glucose
1
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repression. This increase is controlled at the transcriptional level, and is regulated by a
number of factors.
An Overview of Glucose Repression
Glucose repression inhibits the expression of a number of genes in yeast. Many 
genes responsible for the utilization of carbon sources other than glucose, as well as 
genes encoding many enzymes of the TCA cycle, respiration, and gluconeogenesis, are 
glucose repressed. HXK2 (gene name in capital letters means wild type or functional 
allele), which encodes the main hexokinase in yeast, plays an important role in glucose 
repression, as hxk2 (gene name in lower case letters means mutant allele) mutants release 
many genes from glucose repression. A signaling pathway beginning at Hxk2p 
(capitalized gene name followed by a "p" means gene product or protein) appears to be 
partly responsible for suppressing the function of Snflp via the Glc7p-Reglp protein 
complex, which is required for glucose repression [Tu and Carlson, 1995]. While Hxk2p 
can autophosphorylate itself, which led to belief that it may have a kinase activity 
involved in a signaling pathway, its role in glucose repression directly correlates with its 
ability to phosphorylate glucose, indicating that other glucose-6P-sensing intermediates 
exist [Rose et al., 1991].
Snflp is a protein kinase that is required for expression of all glucose repressed 
genes, and snfl mutants are unable to use carbon sources other than glucose [Celenza and
2
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Carlson, 1986]. Snflp is associated with Snf4p, which is required for its function 
[Celenza et al., 1989; Jiang and Carlson, 1996]. One of the functions of Snflp is to 
suppress Miglp function, possibly by direct phosphorylation [Ostling and Ronne, 1998; 
Tzamarias and Struhl, 1994]. MIG1 encodes a DNA binding repressor protein that binds 
the Tuplp-Cyc8p repressor complex, recruiting the complex to act at glucose repressed 
promoters [Tzamarias and Struhl, 1994; Treitel and Carlson, 1995; Williams et al., 1991]. 
Tup Ip and Cyc8p are also required for glucose repression mediated by proteins other 
than Miglp, and for the repression of genes not regulated by glucose [Williams et al., 
1991; Keleher et al., 1992]. Glucose repression in yeast is not fully understood, and it is 
likely that there are other general pathways as well as general and promoter specific 
regulatory proteins yet to be identified (reviewed in [Gancedo, 1998]).
The General Behavior of Glucose Repressible Promoters
The SUC, GAL, and MAL genes are required for the utilization of sucrose, 
galactose, and maltose, respectively. In hxk2, tupl, and cyc8 cells, glucose repression is 
fully relieved from SUC and GAL genes [Johnston et al., 1994; Ronne, 1995]. Miglp 
binding sites are present in many of the promoters of genes involved in using sugars other 
than glucose [Gancedo, 1998; Klein et al., 1998]. In migl cells, partial release from 
glucose repression is observed in many genes, including the SUC, GAL, and MAL genes 
[Klein et al., 1998]. Additionally, in snfl cells, migl mutants are able to utilize galactose
3
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and sucrose as carbon sources, bypassing the requirement of Snflp for utilization of non­
glucose carbon sources [Nehlin et al., 1991; Schuller and Entian, 1991]. Other 
mechanisms must be present to repress the expression of these genes on glucose, as full 
expression of these genes is not observed in migl cells. Still, Miglp appears to play a 
significant role in glucose repression at promoters of genes involved in utilization of 
alternate carbon sources [Klein et al., 1998].
For genes like FBP1, which encodes Fructose 1,6 bisphosphatase, which are 
involved in gluconeogenesis, glucose repression is far stricter. Expression would be 
detrimental to the cell if expressed on glucose, as futile cyclical pathways would arise 
that would deplete ATP levels. At gluconeogenic promoters, glucose repression is 
supplemented by other mechanisms. Expression at these promoters is unaffected in hxk2, 
tup I, and cyc8 cells. Additionally, at the FBPI promoter and other such Miglp binding 
site containing promoters, m igl mutations do not allow any release from glucose 
repression [Ronne, 199S; Lundin et al., 1994; Mercado and Gancedo, 1992]. HXK2, 
TUP I, and CYC8 appear to still play a role in glucose repression at these promoters, but 
are clearly working alongside other regulatory mechanisms. There is evidence that the 
cAMP pathway accounts for some of the additional control over gluconeogenic 
promoters [Hoffman and Winston, 1991; Dombek and Young, 1997]. Like 
gluconeogenic genes, the regulation of ADH2, which has no Miglp binding site, is also
4
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independent of HXK2, TUP1, and CYC8 [Denis and Audino, 1991; Ronne, 1995; 
Dombek etal., 1993].
Genes Affecting the Expression of ADH2
Proper expression of ADH2 requires a number of proteins, including ADR1, a 
classical DNA binding transcriptional activator. There are also a host of more general 
transcription factors. Some are involved in repression, such as SPTIO and SPT6, others 
affect ADH2 expression positively, like CCR4 and CAFl. The association of these 
general factors with other proteins seems to be an important part of their function.
ADR1
ADRl binds the ADH2 promoter at a 22 bp inverted repeat located upstream of 
the TATA element [Eisen et al., 1988]. It is required for expression under nonrepressing 
conditions, and is a target of the cAMP pathway [Ciriacy, 1975; Cherry et al., 1989]. 
Phosphorylation sites on Adrlp that have been shown to be cAMP dependent kinase 
(cAPK) dependent, however, have not been able to completely account for A D R l 
dependent glucose repression [Cherry et al., 1989; Dombek and Young, 1997; Dombek et 
al., 1993]. Sch9p is a protein kinase that is required for maximal ADHl release from 
glucose repression. Its function is unknown, but it is a putative target of cAPK. Sch9p, 
however, does not appear to exert its effects through ADRl [Denis and Audino, 1991].
5
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The REG1 gene has also been identified that, when disrupted, releases A D H l from 
glucose repression in an AD R l dependent manner [Dombek et al., 1993]. The 
mechanism by which Reglp affects Adrlp is, however, unclear, as Reglp is thought to 
act in a pathway with Snflp, which appears to regulate ADH2 expression independently 
of Adrlp [Tu and Carlson, 1995; Denis and Audino, 1991].
Adrlp has been shown to contact two components of the SAGA complex, Ada2p 
and Gcn5p, as well as TFIIB, TBP and numerous TBP associated factors (TAFs) [Chiang 
et al., 1996; Komamitsky et al., 1998]. Other studies show that chromatin remodeling at 
the ADH2 promoter occurs in an Adrlp dependent manner upon the shift from glucose to 
ethanol as the carbon source [Verdone et al., 1997]. Given the histone N- 
acetyltransferase activity of Gcn5p, this suggests a possible mechanism of activation by 
Adrlp. However, while nucleosome disruption is required for expression of ADHl, it has 
been shown that nucleosomal rearrangement alone is insufficient for maximal activation 
of ADH2 [Verdone et al., 1997]. The ambiguity surrounding the role of Adrlp in glucose 
repression shows that glucose repression of ADH2 is complex, and exerted by more than 
one mechanism.
SPT10 and SPT6
Two genes, SPTIO and SPT6, have also been identified that are required for the 
repression of many genes Penis, 1984; Natsoulis, et al., 1991; Neigebom et al., 1986].
6
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Mutations in both SPT10 and SPT6 allow increased expression of ADH2 under repressing 
conditions [Denis, 1984]. Both genes were identified as suppressors of a TY LTR 
insertion mutation in the HIS4 promoter, his4-9128 [Winston et al., 1984; Natsoulis, et 
al., 1991]. TY transposon insertion into a promoter generally has significant effects on 
the expression of the gene under the control of that promoter. The 8 regions flanking TY 
elements can undergo 8-8 recombination, removing the TY element, but leaving a 8 
element in the promoter. The remaining 8 element can still alter expression. The his4- 
9128 locus is one such case, in which a 5 element at position -912 of the H1S4 gene 
abolishes HIS4 expression. Cells containing this mutation cannot grow on minimal 
media lacking histidine, spt mutations allow growth on histidine by allowing expression 
of HIS4 [Winston et al., 1984 and references therein].
sptlO alleles allow increased transcription generally under repressing conditions. 
SPT10 has also been shown to be required for expression of certain histone genes 
[Dollard et al., 1994]. Two copies of histones H2A and H2B are encoded in HTA1-HTB1 
and HTA2-HTB2, each pair being divergently transcribed from a single promoter 
[Hereford et al., 1979]. SPT 10 is required for the expression of HTA2-HTB2 [Dollard et 
al., 1994]. Similarly, there are two copies of histone H4, HHF1 and HHF2, and SPT10 is 
required for HHF2 expression [Smith and Murray, 1983; Dollard et al., 1994]. 
Additionally, sequence alignments have shown that SptlOp has similarity to histone N-
7
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acetyltransferases like GCN5 [Neuwald and Landsman, 1997]. While this function for 
SptlOp is still hypothetical, it suggests that SptlOp may have an additional, more direct 
effect on histones. SPT6 is an essential gene that also affects the expression of many 
genes [Swanson et al., 1990 and references therein]. Spt6p interacts directly with 
histones and has been shown to be able to assemble nucleosomes in vitro, and mutations 
in SPT6 have been shown to suppress lowered expression of SUC2 resulting from a snf5 
mutation. This effect was shown to be at the level of chromatin structure [Bortvin and 
Winston, 1996]. SPT6 may also have a role in transcriptional elongation [Hartzog et al., 
1998]. These genes, therefore, appear to exert their effects on transcription through 
chromatin structure. This would explain their widespread effects over seemingly 
unrelated genes.
CCR4
CCR4 was identified as a mutation that suppressed the increased AD H 2  
expression on glucose caused by an sptlO allele, crel-l [Denis, 1984]. The interaction of 
CCR4 with SPT 10 is not limited to the ADH2 promoter, as ccr4 can also suppress sptlO, 
as well as spt6, at the his4-912S locus [Denis and Malvar, 1990]. CCR4 is required for 
maximal expression of ADH2 and other nonfermentative genes [Denis, 1984]. Mutations 
in CCR4 also have numerous varied growth defects under many different conditions [Liu 
et al., 1998]. Phenotypes of a  ccr4 strain are presented in Table l . l .  CCR4 is required
8
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for cell wall integrity, as the osmotic stabilizer sorbitol can suppress a number of these 
growth defects [Liu et al., 1998; Chang et al., 1999]. There is evidence that CCR4 may 
be involved in other processes such as amino acid metabolism, cell cycle progression, 
and DNA repair, although these effects may likely be due to other proteins whose 
expression is regulated by Ccr4p [McKenzie et al., 1993; Liu et al., 1997; Schild, 1995]. 















Wild Type + + + + + + + +
ccr4 - -(+) w (+) -(+) - - - -
cafl - -(w) -(+) • - w - -
dbfl w W(+) w (+) - ND - - -
notl . ND w(w) ND - ND - -
not2 - ND -(+) ND . ND - w
not3 + ND +(+) ND + ND + w
not4 w ND -(w) ND w ND - -
Table 1.1: Phenotypes of Mutations of CCR4-NOT Complex Components.
Sorb. = Sorbitol, Stauro. = Staurosporine, w = weak growth, ND = no data. Data in 
parentheses refers to growth on plates containing 1.0 M sorbitol.
CAF1 and DBF2
In an experiment done to identify proteins that associate with Ccr4p, two genes, 
CAFl and DBF2, were isolated using the two-hybrid system. The interaction of Ccr4p 
with Caflp and Dbf2p has been confirmed by westerns and for Caflp, biochemically by
9
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gel filtration and chromatographic protein purification [Draper et al., 1995; Liu et al., 
1997].
CAFl in yeast (yCAFl) is an evolutionarily conserved protein with homologs in 
humans, mouse, C. elegans and A. thaliana. Murine CAF1 (mCAFl) and C. elegans 
CAFl (cCAFl) interact with Ccr4p in two hybrid experiments, and m C A F l can 
functionally substitute for yCAFI [Draper et al., 1995]. DBF2 is a cell cycle regulated 
protein kinase, which has been shown to function through, but not limited to, its Ccr4p 
interaction. Progression of the cell through late mitosis requires Dbf2p [Liu et al., 1997]. 
A physical contact between Dbf2p and Dbilp/Moblp was observed that is required for 
this progression [Komamitsky et al., 1998].
Phenotypes of strains carrying disruptions in the CAF1 or DBF2 gene are similar 
to that of a ccr4 strain (See Table 1.1), and double mutants studied show no increase in 
the severity of these phenotypes. Interestingly, cafl and dbf2 mutants can also suppress 
the effect of sptlO at ADH2, and cafl can suppress spt6 [Draper et al., 1995; Liu et al., 
1997]. This suggests that they may have a similar function, or function in the same 
pathway or complex.
NOTUNOTS and the CCR4.NOT Complex
The NOT complex consists of the Notlp-Not5p proteins, which were initially 
identified individually as negative regulators of transcription at the nonconsensus TATA
10
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element of the HIS3 gene [Liu et al., 1998; Collart and Struhl, 1994; Collart and Struhl, 
1993], The HIS3 promoter contains a consensus TAT AAA element that is responsive to 
activation as well as a nonconsensus TATA element that is not. NOT genes repress 
transcription from this nonconsensus TATA element [Collart and Struhl, 1994]. Further 
studies determined that the Notlp-NotSp proteins are components of a 1.0 MDa CCR4- 
NOT complex that affects transcription both positively and negatively. This complex 
contains Ccr4p, Caflp, the five NOT proteins (Notlp-Not5p) and two other proteins, 
Caf40p and Cafl30p [Liu et al., 1998; C. Denis, personal communication]. Disruptions 
in NOT genes results in ccr4-like phenotypes (See Table l.l), consistent with the model 
that CCR4 and its associated factors function in a complex. Specifically, not4 could 
suppress the effects of sptlO on ADH2.
There is evidence that the effects of NOT proteins on the nonconsensus TATA 
element of the HIS3 gene, as it was originally characterized, are independent of its 
association with the CCR4 complex. Not2p was shown to have two domains. The C- 
terminus of Not2p appears to function within the context of the CCR4 complex, and 
mutations affecting this domain result in ccr4-Vkt phenotypes. The N-terminus contacts 
the SAGA complex and functions in NOT-type repression. Mutations in the N-terminus 
leaves CCR4 complex function unaffected [Benson et al., 1998].
The organization of NOT proteins in the CCR4-NOT complex was also 
investigated and it was revealed that there exists a physical and functional separation of
11
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Ccr4p and Caflp from Not2p-Not5p proteins. ccr4 and cafl alleles were synthetically 
lethal with not2 and notS, and could suppress the NOT phenotype of not4 strains, while 
ccr4 could suppress not3 [Bai et al., 1999]. The multifunctionality of the CCR4-NOT 
complex has yet to be fully understood.
Evolutionary Conservation of the CCR4-NOT Complex
This complex appears to be evolutionarily conserved. Like CAF1, homologs of 
CCR4 and the NOT genes have been found [Albert et al., 2000; Dupressior et al., 1999]. 
CCR4 homologs have been found in C. elegans, Drosophila, and humans (hCCR4). The 
nature and functions of these homologs is unknown, but there is convincing evidence that 
there is a human CCR4 complex whose function is conserved.
Human homologs of NOT1-NOT4 and a second human homolog of yCAFl 
(fiCAUF, human CAf-LIke Factor) have recently been identified [Albert et al., 2000]. 
hNOTl-hNOT3 and hCAUF mRNAs are expressed in all tissue types, albeit at different 
levels. Additionally, expression levels of hNOT and hCAUF mRNAs are similar in each 
tissue, unlike the previously described hCAFl, suggesting that hCAUF is the true human 
homolog of yCAFl. In two hybrid experiments, both yNOTI and hNOTl interact with 
hN O T2, hNOT4, and hC AU F . hCAUF also interacted with hNOT3, and 
immunopreciptiation experiments confirmed this result. yCCR4 and hCALIF interacted 
strongly in the two-hybrid system. Finally, hNOT4, and to some degree hNOT3, could
12
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complement for their respective genes in yeast. These findings strongly support the 
evolutionary conservation of the CCR4-NOT complex.
Complexes and Gene Regulation
While Ccr4p functions in the 1.0-1.2 MDa CCR4-NOT complex, a larger, 1.9 
MDa complex exists that consists of the CCR4-NOT complex with, perhaps, a number of 
proteins that are less tightly associated with the 1.0-1.2Mda complex [Liu et al., 2001]. 
Protein complexes involved in transcription have been found to play a significant role in 
yeast. Most notable of these complexes is the RNA polymerase H holoenzyme, but there 
is also a Paflp holoenzyme, as well as the SNFfSWI, SAGA, and SPT complexes.
RNA polymerase II holoenzvme
The RNA polymerase II (POL II) holoenzyme in yeast contains POL n , general 
transcription factors (GTFs) TF11B, TF11F, TF1IH, and a mediator complex of SRB and 
other proteins [Koleske and Young, 1994]. This holoenzyme in combination with TFllE 
and TATA binding protein (TBP) is able to initiate transcription in vitro that is 
responsive to activators. POL II and the GTFs are highly conserved proteins, and 
versions of the holoenzyme have been found in many different organisms, with minor 
differences in some components. Specific contacts between DNA binding activators like
13
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VP16, Gcn4p, and Gal4p and mediator components provide a compelling model for their 
mechanism of transcriptional activation [Myer and Young, 1998; Weinmann, 1992].
SNFiSWI Complex
The SNF/SWI genes have been shown to be required for transcription at many 
promoters, including HTAI-HTB1. A complex of Swilp, Snf2p, Swi3p, Snf5, Snf6p, and 
other proteins has been shown to be able to contact histones H2A and H2B and reposition 
histones in an ATP dependent manner, providing a mechanism for transcriptional 
activation [Peterson et al., 1994]. Specific contacts between GCN4 and other DNA 
binding transcriptional activators with the Snf/Swi complex have been observed that are 
required for the activators' function [Neely et al., 1999]. The Snf/Swi complex has also 
been shown to associate with Srb proteins in the mediator complex of the holoenzyme, 
and the resulting complex can disrupt nucicuaomes in an ATP dependent manner [Wilson 
et al., 1996]. While this association exists, Snf/Swi complexes have been purified 
independently of the holoenzyme, and specific interactions between the complex and 
GCN4 have not involved the holoenzyme or mediator complex [Natarajan et al., 1999]. 
It appears that at certain promoters, the holoenzyme, the Snf/Swi complex, and the 
SAGA complex are all required independently, but in a coordinated fashion to achieve 
maximal activation [Neely et al., 1999; Natarajan et al., 1999; Roberts and Winston, 
1997].
14
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SAGA Complex
The SAGA complex consists of SPT and ADA proteins and GcnSp [Roberts and 
Winston, 1997]. Gcn5p is a histone N-acetyltransferase (HAT) and is involved in the 
regulation of many genes [Pollard and Peterson, 1997; Kuo et al., 1996; Grant et al., 
1997; Brownell et al., 1996]. Histone acetylation has been shown to correlate with the 
remodeling of chromatin, resulting in increased transcription [Allfrey et al., 1964; Kuo et 
al., 1996]. The SAGA complex has been shown to exert its effects on transcription levels 
through specific DNA binding proteins as well as affecting gene expression globally 
[Dudley et al., 1999; Roberts and Winston, 1997]. The SAGA complex also contacts 
TBP and contains TBP associated factors (TAFs) that are required for its function [Grant 
et al., 1997]. Numerous synthetic lethalities between SAGA complex components and 
SNF/SWI and SRB genes show that these complexes function in an interdependent and 
parallel fashion [Roberts and Winston, 1997].
SPT Complex
A complex consisting of Spt4p, Spt5p, and Spt6p has long been proposed to be 
involved in general repression of transcription [Swanson and Winston, 1992]. In support 
o f this, many SPT  proteins have been shown to be involved with chromatin structure 
[Bortvin and Winston, 1996; Winston and Carlson, 1992]. Mutations in SPT4, SPT5, or 
SPT6 result in increased expression at a number of genes [Swanson and Winston, 1992;
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Compagnone-Post and Osley, 1996; Denis and Malvar, 1990], and there is genetic and 
physical evidence that they are involved in nucleosome assembly. Spt6p binds histones 
and alters chromatin structure in vivo, and has been shown to assemble nucleosomes in 
vitro [Bortvin and Winston, 1996]. The histone interactions of Spt6p implies a 
mechanism by which spt6 alleles suppress snf2, snf5, and snf6 mutations [Laurent et al., 
1991; Neigebom et al., 1987]. Loss of ability by the holoenzyme to disrupt nucleosomes 
in snf5  strains is compensated by spt6 mutations which compromise nucleosome 
assembly [Bortvin and Winston, 1996], Additionally, mutations in SPT4, SPT5, and 
SPT6  interact genetically with RNA polymerase II and elongation factor THIS, 
suggesting a role for these genes in transcriptional elongation [Hartzog et al., 1998]. 
Hartzog's SPT complex appears to contain Spt4p and SptSp, but not Spt6p, although their 
similarities in function and mutant phenotypes place them together until more specific 
roles for each protein is defined.
Paflp Hglwnam c
There is a second identified RNA polymerase II complex containing Paflp and 
Cdc73p [Shi et al., 1997]. Recently, Ccr4p was found to be physically associated with 
this complex [Chang et al., 1999]. When disrupted, many of the components of this 
complex, including CCR4, result in reduced expression of a number of genes involved in 
cell wall biogenesis. Experiments linking the Paflp holoenzyme to protein kinase C
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signaling showed that paflm pkl and p a flp kc l double mutants showed no or mild 
increase in severity of growth phenotypes. FKS1 (encodes a component of beta-1,3- 
glucan synthase; involved in cell wall biogenesis [Inoue et al., 1995]) mRNA levels are 
reduced in pafl, pkcl, and mpkl backgrounds, and no cumulative effect was observed 
with the double mutants [Chang et al., 1999]. This is evidence that this complex is 
downstream of Pkclp (protein kinase C) in a regulatory pathway affecting genes involved 
in cell wall integrity.
CCR4 Complexes
Much research has been conducted on the 1.0-1.2 MDa CCR4-NOT complex (see 
above) but CAF16, CAF4, DBF2, and MOB1 have all been detected in a 1.9 MDa 
complex. CAF4 and CAF16 association in this larger complex is dependent on CCR4, 
suggesting that they are true components of the CCR4-NOT 1.9 MDa complex. 
Furthermore, a two-hybrid library screen for interactions with Cafl6p identified Srb9p. 
It was found that both Cafl6p and Caf4p could interact with Srb9p in a Ccr4p dependent 
manner. Multiple immunoprecipitation experiments showed interactions between Srb9p 
and Caf4p, Ccr4p, Notlp, and Not2p, between SbrlOp and Ccr4p and Dbf2p, and 
between Srbllp and Ccr4p, Notlp, and Not2p [Liu et al., 2001]. SrblOp and Srbl lp are 
a cyclin-dependent kinase (cdk)-cyclin pair that appears to be involved in Tuplp-Cyc8p 
repression and phosphorylation of the C-terminal domain (CTD) of POL II [Liao et al.,
17
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1995; Kuchin and Carlson, 1998]. As Srb9p, SrblOp, and Srbl lp are components of the 
holoenzyme, it is by this association that the CCR4-NOT complex may regulate 
transcription. This line of research also revealed that srb9 and srblO disruptions could 
suppress elevated ADH2 expression on glucose caused by sptlO.
Research Leading Up to This Work
Previous Results
SPT10 and SPT6 were originally identified as CREl and CRE2, respectively. The 
mutations crel-1 and cre2-l partially released ADH2 from glucose repression, and were 
produced by screening for the ability to grow on plates containing Antimycin A. 
Antimycin A acts as an inhibitor of cellular respiration in which it inhibits transfer of 
electrons from cytochrome b to cytochrome cl in complex m  of the electron transport 
chain [Matthews, 1990]. Without the ability to generate ATP via oxidative 
phosphorylation, yeast cells are entirely dependent on glycolysis and, therefore, ADH  
enzymes for energy generation (see Figure 1.1). The strain in which the crel-1 and cre2- 
1 alleles were identified contained a  nonfunctional allele of ADH1, adhl-11, so all of the 
ADH activity in these cells was dependent on expression of ADH2. The partial release 
from glucose repression of ADH2 in crel-l and cre2-l strains is sufficient to allow 
growth in the presence of glucose and Antimycin A (Denis, 1984]. It should be noted
18
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that while the yeast genes ADH3 and ADH4 encode ADH enzymes, their contribution in 
this plate assay are insignificant.
SPT 10 and SPT6 were shown to act independently of ADRI and SNF1, and, 
therefore, represent a new mechanism by which ADH2 is glucose repressed. The 
increased expression of ADH2 resulted in an inability of these strains to grow in the 
presence of allyl alcohol. Allyl alcohol can be converted by ADH  enzymes to acrolein, 
which reacts rapidly with proteins through the formation of schiff bases with lysine, 
histidine, and serine residues. Acrolein is also believed to react with the nitrogen 
containing rings of nucleotides and NAD41. This unregulated damage quickly kills the 
cell. To further analyze the factors responsible for the increased expression of ADH2, a 
screen was conducted to identify suppressors of sptlO effects on ADH2 expression using 
allyl alcohol.
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Figure 1.1: Metabolic Scenarios in Relevant Yeast Strains Grown on Glucose.
1. In wild type strains, fermentation is the preferred pathway.
2. In strains lacking ADH1, fermentation is not possible, and cells must utilize oxidative 
phosphorylation, leaving them sensitive to Antimycin A.
3. In cells lacking AD H I and SPT10,ADH2 is expressed at high enough levels to 
ferment, making them resistant to Antimycin A, but sensitive to allyl alcohol due to 
the presence of ADH activity.
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Denis [1984] reported that a screen for mutations that allowed ad h l-ll crel-1 
cells to grow on allyl alcohol produced 83 colonies. Of these 83, only nine were 
Antimycin A sensitive, indicating that the mutations were recessive and that AD H  
activity in these cells was greatly reduced. One of these mutations was shown to be in 
the ADH2 gene itself, the other eight mutations were in the CCR4 gene.
Further research on Ccr4p function has established a number of interactions and 
identification of the CCR4-NOT complex. In this research, mutations in two additional 
genes, CAF1 and DBF2 were found to suppress sptlO atADH2 [Draper et al., 1995; Liu 
et al., 1997], These three genes, at the time, represented the only genes capable of 
suppressing sptlO. The products of these genes physically interact with Ccr4p, and 
strains lacking these genes have similar phenotypes to ccr4 strains.
During the course of this project, NOT4, SRB9, and SRB10 were identified by 
their physical association with the CCR4-NOT complex, all of which can suppress sptlO 
and interact with the CCR4 complex [Liu et al., 1998; Liu et al., 2001]. This supports the 
notion that sptlO suppression is a characteristic of CC7W-like gene regulation.
The Objective of This Project
Given this information, the screen used to identify CCR4 originally was slightly 
modified and was performed again in the expectation that new genes affecting ADH2 
expression, and possibly components of the CCR4 complex, would be identified.
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Mutations were screened for that would restore the ability of the crel-I strain to grow on 
allyl alcohol. There is a narrow range of ADH activity that allows growth on allyl 
alcohol and resistance to Antimycin A at the concentrations used in this study (see Figure 
1.2). In the screen previously described, nearly 90% of the positives produced were not 
Antimycin sensitive. Therefore, the condition that revertants must be Antimycin A 
sensitive was not used as a basis for elimination from further investigation.
Since the phenotypes of ccr4, c a f l , db/2, and notl-not5 strains are similar, 
particular attention was paid to revertants that also shared these similar phenotypes. This 
was done for two reasons, to artificially increase the probability of finding other CCR4- 
like genes, and to aid in the process of characterizing and cloning these genes. With 
these modifications, this screen was still likely to produce mutations in ccr4, as well as 
many other genes.
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Figure 1.2: ADH Activity Levels and Sensitivity to Antimycin A and Allyl Alcohol.
In sptlO cells, ADH2 expression results in increased ADH activity (above the "allyl 
alcohol threshold"), resulting in allyl alcohol sensitivity. Conversely, in a sptlO, ccr4 
double mutant strain, ADH levels are reduced to such an extent (below the "Antimycin A 
threshold") that the cells are dependent on oxidative phosphorylation, resulting in 
Antimycin A sensitivity. There exists a range of ADH activity that causes no sensitivity 
to either compound. Such mutations (labeled"-?-") were sought in this work.
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All E. coli strains used in this project are DH5-alpha strains obtained from Gibco 
BRL. E. coli strains were grown in Luria Broth (1% Difco Bactotryptone, 0.5% Difco 
Yeast extract, 0.5% NaCl). For solid media 2% Agar (Sigma) was added to the mixture 
before it was autoclaved. Ampicillin (Sigma) was added to the sterile media at a 
concentration of 50pg/ml where required.
E, C</li Transformation
Standard Transformation
20|xl of subcloning efficiency competent DH5-a cells (Gibco BRL) were thawed 
on ice beforelOOng to lpg of DNA was introduced to the sample. The mixture was 
incubated at O'C for 30 min. Samples were heat shocked at 37°C for 25 seconds and 
incubated at 37°C for 20-60 minutes, with shaking, before plating onto selective media. 
Plates were incubated overnight at 37°C.
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High Efficiency Transformation
When rescuing plasmid DNA from yeast strains, 100 to 200pl of max efficiency 
competent DHS-a cells (Gibco BRL) were thawed on ice. 5ill of the DNA solution 
resulting from a yeast plasmid prep was added to the cells and the mixture was incubated 
at 0°C for 30 min. Samples were heat shocked at 42°C for 45 seconds. The cells were 
incubated at 37°C for one hour in a shaker and plated onto selective media. Plates were 
incubated overnight at 37°C.
Isolation of Plasmid DNA from E. coli 
STET MiniPrep
Approximately 1.5ml of E coli from an overnight culture in LB-Amp was 
centrifuged and the cell pellet resuspended in 210|i.l of STET solution (lOmM Tris pH 
8.0, 50mM EDTA, 0.5% Triton X, 8% Glucose (Final pH 8.0)). I5|i.l of lOmg/ml 
lysozyme was added. This mixture was inverted repeatedly and boiled for 50 seconds. 
The mixture was then immediately centrifuged at room temperature in a tabletop 
Eppendorf centrifuge for 6 minutes at high speed. The pellet was removed with a 
toothpick, and an equal volume of isopropanol was added to the supernatant. The sample 
was then incubated at room temperature for five minutes before centrifugation at4°C for 
ten minutes. The supernatant was discarded and the pellet was washed with 70% ethanol.
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The pellet was dried and resuspended in SOpl of sterile water. DNA samples were stored 
at -20°C.
Wizard MiniPrep
For DNA preps requiring high purity DNA, 1.5mL of culture were grown 
overnight in LB-Amp and the Wizard Miniprep kit (Promega) was used to isolate the 
DNA.
Wizard MegaPrep
For large scale DNA preps 0.SL of culture were grown overnight in LB-Amp and 
the Wizard Plus MegaPrep kit (Promega) was used to isolate the DNA (typical yields of 
0.1-1 mg/ml).
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All yeast strains used in this project are listed in table 2.1.
Strain Relevant Genotype
553-4b MATaadhl-11 adh3 crel-1 ural leu2 trpl
5534b-10 MATaadhl-11 adh3 crel-1 ccr4-10 ural leu2 trpl
43-2B MATa adhl-11 adh3 ural his4
43-2B-M1 MATa adhl-11 adh2-l adh3 ural his4
1076-2c MATa ura3 his3 Ieu2 trpl ccr4::URA3
1005-2-3c MATa adhl-11 his3 ura3 trpl leu2 cafl::LEU2 sptlO::trpl
l005-2-3c-s MATa adhl-11 his3 ura3 trpl leu2 cafl::LEU2 sptlO::trpl
BAl-l MATa adhl-l 1 leu2 asgl-4-6
BA2-1 MATa adhl-11 leu2 his4 asg2-l-42
BA3-1 MATa adhl-11 leu2 asg3-5-17
BA4-1 MATa adhl-11 leu2 trpl asg4-4-33
BA5-1 MATa adhl-l I leu2 trpl asg5-5-37
BA6-1 MATa adhl-11 trpl asg6-6-72
994-2 MATa adhl-11 his3 ura3 leu2 sptlO::TRPl
994-2-AASG2 MATa adhl-l 1 his3 ura3 leu2 sptlO::TRPl asg2::URA3
612-ld MATaadhl-11 his3 ura3 leu2 trpl
612-ld-AASG2 MATaadhl-11 his3 ura3 leu2 trpl asg2::URA3
EGY188 MATahis3 ura3 leu2 trpl Lex-OP-LEU2
EGY188-AASG2 MATa his3 ura3 leu2 trpl Lex-OP-LEU2 asg2::URA3
EGY191 MATa his3 ura3 leu2 trpl Lex-OP-LEU2
DY3462 ?
DY3462-S10-2 ?
LGY101 MATa rat7-l his3A200 ura3-52 leu2Al
AEMY19 MATa trplAl his3A200 ura3-l leu2-3, -112
Table 2.1: Yeast Strains Used in This Study.
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Yeast Media
Yeast strains were grown non-selectively in YEP (1% Difco Yeast extract, 2% 
Difco Bacto peptone, 2% or 8% Glucose, and 20mg Adenine and Uracil per liter) liquid 
media. For solid media (YD plates) 2% Agar (Sigma) was added to the liquid before 
autoclaving.
lOmM allyl alcohol (AA) plates were made by the addition of 700^1 of allyl 
alcohol to the media after autoclaving. Antimycin A (At) plates were made by spreading 
125pl of an 8mg/ml solution of Antimycin A onto a YD plate. YEPG media and plates 
replaced glucose with 3% glycerol.
Synthetic complete (SC) media (6.7% Difco Yeast nitrogen base, lOmls Dropout 
mix (1.0% each of Tryptophan, Histidine, Arginine, and Methionine; 1.5% each of 
Tyrosine, Leucine, and Lysine; 2.5% Phenylalanine, 5.0% Aspartic acid, 10.0% 
Threonine), 2% Glucose) was used to select for various yeast markers. Solid media 
contains 2% Agar (Grade A, Becton Dickenson).
X-Gal plates were buffered by the addition of salts (0.1M KH2P04, l5mM 
(NH4)2S04,7.5mM KOH, pH 7.0) that were autoclaved separately as a 1 OX solution. X- 
gal was added at a concentration of 5|ig/ml, from stock solution of 20mg/ml in DMF.
5' Flouro-orotic acid (FOA) plates were made containing 0.1% FOA. The FOA 
was dissolved overnight in water at 50°C and added to the media after it was autoclaved.
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Minimal media (0.67% Difco Yeast nitrogen base, 2% glucose with 20mg 
Tyrosine per liter) with 2.5% agar was used to make solid B 1 plates.
Potassium Acetate (KAc) plates (0.25% Yeast Extract, 0.1% Glucose, 2.0% KAc, 
2.0% agar supplemented with 20pg/ml each of Adenine, Leucine, Lysine, Methionine, 
Tryptophan, and Uracil) were used to sporulate yeast.
Transformation
For library transformation, an overnight culture in either rich or selective media 
was used to inoculate 50ml YEPD. The cells were grown until they reach an O D ^ of
1.0 +/- 0.1. The cells were collected by centrifugation at 3,000 rpm at room temperature 
for 5 min and washed with sterile water. The following solutions were added to the pellet 
in the order listed in table 2.2.
Solution Quantity
50% PEG M.W. 3350 2.4ml
(Sigma)
1.0M Lithium acetate 360ml
SS-DNA 250ml
Library DNA (~100pg/ml) 100ml
Sterile water 400ml
Table 2.2: Solutions Used for Yeast Transformation.
Solutions listed were prepared in the concentrations indicated. DNA from salmon sperm 
(Sigma) was made to a  concentration of lOmg/ml in water and sheared by passing it 
through an 18-gauge syringe. The resulting sheared DNA was diluted to 2mg/ml, boiled 
for 5 min, and cooled on ice immediately.
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The cells were resuspended completely and incubated at 30°C for 30 min. The 
cell suspension was heat shocked at 42°C for 30. The cells were collected by 
centrifugation, plated onto selective media and incubated at 30°C for 4-5 days.
Standard transformations were performed by obtaining fresh cells from a 1-2 day 
old plate. The cells were washed with 50pl of water. The cells were treated as above 
except the volumes for the various additions are 1/I0lb of those listed. The treated cells 
were incubated at 30'C for 30 min and heat shocked at 42°C for 20 min before plating to 
selective media.
Loss of Plasmid and Determination o f Plasmid Dependency
Loss pf Plasmid
A strain containing a plasmid was transferred to a YD plate and incubated at 30°C 
for 3-4 days before inoculation of 200pl of YEP supplemented with 2% glucose. After 
overnight growth, a toothpick was briefly dipped into the culture and streaked out on a 
YD plate. After 3-4 days, colonies were replicated to a YD plate and an SC plate lacking 
the appropriate amino acid or nucleotide. Cells that did not grow on the SC plate had lost 
the plasmid and could be retrieved from the YD plate.
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Determination of Plasmid Dependency
To determine plasmid dependency, a third plate was included in the final (replica 
plating) step to test the phenotype of interest (i.e. 8mM caffeine). This third plate was 
compared to the SC plate, and if growth patterns were identical the effect was deemed to 
be plasmid dependent.
Two Hybrid System Experiments
The Two Hybrid System
Protein interactions were examined using the Two Hybrid Interaction Trap 
system. The bait plasmid was generated by subcloning the bait open reading frame into 
the plasmid 202-2. 202-2 contains the open reading frame of the bacterial LexA gene 
(amino acids 1-202) driven from the yeast ADH1 promoter. The resulting plasmid was 
transformed into strain EGY188 containing p34. The LexA fusion protein was then 
tested for activation of expression of the reporter genes by itself.
To test potential protein interactions, constructions based in plasmid pJG4-5 were 
used in strain EGY191. EGY191 is the opposite mating type version of EGY188. 
Plasmid pJG4-5 contains a B42 activation region in frame with a region that codes for the 
HA1 epitope used for antibody detection. Genes can be subcloned in frame after the 
HA1 epitope to express fusion proteins. Expression in yeast is driven from a galactose 
inducible promoter. EGY188 containing p34 and a LexA fusion construct was crossed to
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EGY191 containing a B42 fusion construct. The resulting diploids were then tested for 
evidence of interaction.
Test for Activation/Interaction
The LEU2 promoter in EGY188 contains a LexA operator. The LEU2 gene in 
this strain is transcribed only by activation through this LexA operator. Thus, growth on 
SC plates lacking Leucine is indicative of activation either by the LexA fusion alone or 
interaction with a B42 fusion protein. The reporter plasmid p34 was used in all 
experiments as another means of detecting activation or fusion protein interaction. This 
plasmid contains a LacZ gene with 8 concatenated LexA operators in its promoter. 
Expression of LacZ is driven solely by these operators, providing a means of detecting 
activation or protein interactions when grown on X-Gal plates (blue color).
Isolation of Plasmid DNA
Yeast from a SOml overnight culture grown to an O D ^ of at least 1.0 were 
washed with sterile water and resuspended in 0.5ml S buffer (lOmM KP04 pH7.2, lOmM 
EDTA, 50mM P-mercapto-ethanol (Sigma), 50pg/ml Zymolyase). The cell suspension 
was incubated at 37°C for 30 min. The cells were lysed by the addition of 0.1ml lysing 
solution (0.25M Tris pH7.5, 25mM EDTA, 2.5% SDS) and the mixture was vortexed 
before incubation at 65‘C for 30 min. The mixture was neutralized using 166pl 3 M
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Potassium acetate and chilled on ice for 10 min. The sample was centrifuged and the 
supernatant collected. DNA was precipitated by adding 0.8ml ice cold ethanol and 
incubating on ice for 10 min. The pellet of DNA was washed with 70% ethanol, and 
dried. The dried pellet was treated with the Wizard Miniprep kit (Promega) to purify the 
DNA. Usually, S|ii was used to transform E. coli as described above.
Mating Type Determination
The mating type of strains was determined using tester strains KY42S and 
KY426. Cells were mixed with each strain on a YD plate and allowed to grow overnight 
at 30°C. The cells were then replica plated to a B 1 plate. The lack of a functional LYS1 
gene in strains KY425 and KY426 combined with the leu2 genotype of strains tested 
allowed only diploids to grow on this strain. Additionally, diploids would only result 
from the mixing of the strain with one of the two tester strains, as only yeast of opposite 
mating types can mate. Thus, growth at the site of mixing with one tester strain and not 
at the other would reveal the mating type of the strain being tested. Lack of growth at 
both intersections, or sometimes sparse, irregular growth, is typical of diploid strains.
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Matin? Type Conversion
To change mating type of ural strains, that strain was crossed to 43-2B and the 
resulting diploids were grown overnight at 30°C on YD plated supplemented with 8% 
glucose. The cells were replica plated to KAc plates and incubated at 30°C for 3-5 days. 
Cells were scraped off of the plates, resuspended in lOOpl of sterile water, and vortexed 
at room temperature for five minutes. This kills a majority of diploids, and separates 
tetrads into four individual cells. The cells were then plated onto a YD plate and 
incubated at 30°C for 3-5 days. Approximately 12 individual colonies were selected and 
mating type was determined.
To change mating type of ura3 strains, plasmid M l023 was transformed into the 
strain. M1023 contains a galactose inducible HO gene. Expression of the HO gene 
initiates a switch in mating type. Fresh transformants were place onto SC plates lacking 
Uracil supplemented with 2% galactose/raffinose. After two days growth, cells were 
streaked to single colonies and were tested for mating type as described above.
Checking for Disruption Using PCR
A scrape of cells from a fresh colony was washed with sterile water and the cell 
pellet microwaved for 2 min. The pellet was resuspended in PCR cocktail containing IX 
Taq buffer, 2 mM dNTPs, 50 pmol each of primers and 0.5U Taq polymerase. These
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primers anneal to the DNA sequences flanking the disruption. After 30 cycles of PCR 
the samples were electrophoiesed on a 1% agarose gel. The presence of a disruption in 
the cells was determined by the presence of a PCR product that was 1.1 Kbp larger than 
the PCR product produced in a control strain. The 1.1 Kbp increase in size is due to a
1.1 Kbp fragment of DNA containing the URA3 gene inserted in the gene.
Generation of Diploid Strains
Cells of opposite mating type were taken from fresh streaks and mixed on a YD 
plate. The cells were incubated for 1-2 days at 30°C. Generally, selective plates that 
would not allow the two haploid strains to grow, but did allow the resulting diploids to 
grow were used to select for diploids. If this was not possible, cells from the intersection 
of the two strains were streaked to single colonies on a fresh YD plate. Approximately 
12-18 colonies were then selected for mating type determination.
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Molecular Biology Methods
Elasmids
Plasmids used in this research are listed in table 2.3.
Plasmid Name Description
4-26-1 YCp50 genomic clone containing CAF1
1-42-1 YEpl3 genomic clone containing ASG2/YDR206w
5-17-1 YEpl3 genomic clone containing ASG5/ATP17
5-17-2 YCp50 genomic clone containing ASG5/ATP17
1-42-KO Used for making asg2::URA3 disruptions
LexA-l-42 LexA-Asg2p fusion
1-42-1-ANcoI Internal deletion of ASG2 (A a.a. 456-783)
5-17-Eco/Sal pRS315 containing ATP17 and LSM6









Table 2.3: Plasmids Used in This Study.
Plasmid Constructions
1-42-KO
The EcoRI-HindlH fragment containing the 5’ end of ASG2 on plasmid 1-42-1 
was subcloned into pUC18. The resulting plasmid was digested with Bgin and a  BamHI
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fragment containing the URA3 gene was cloned into the Bgin site. The resulting plasmid 
was named 1-42-KO. This plasmid was digested with EcoRI and Hindm, and the 
resulting fragments were transformed into the strain in which the disruption was to be 
created. Cells were plated onto SC plates lacking Uracil, and after three days colonies 
were obtained that contained the disruption asg2::URA3. This was confirmed by PCR 
using primers that flank the Bgin site of ASG2. A SOObp fragment of DNA is generated 
by PCR from a strain containing a functional ASG2, while strains with a disrupted 
asg2::URA3 produce a band of 1.6Kbp, indicating that the 1.1 Kbp DNA fragment 
containing the URA3 gene has indeed been inserted in the ASG2 locus. All asg2::URA3 
disruptions were generated and confirmed by this method.
LexA-1-42
The Bglll-Sall fragment of plasmid 1-42-1 contains the entire ASG2 coding 
region except for the first nine amino acids. LexA 202-2 contains the LexA DNA 
binding protein from E. coli under the control of the yeast ADHl promoter. LexA 202-2 
was digested with BamHI and Sail, and the Bglll-Sall fragment of plasmid 1-42-1 was 
cloned in frame to create a LexA-ASG2 fusion protein.
1-42-1-ANcoI
The three Ncol sites on plasmid 1-42-1 are all contained within the coding region 
of ASG2. Digestion of 1-42-1 released two Ncol fragments, and religation of the vector
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produced an in-frame ORF of ASG2 with an internal deletion of amino acids 456-783. 
This plasmid was named 1-42-1-ANcoI.
Plasmid Libraries
Two genomic libraries were used in this work. Both are yeast genomic libraries 
with a LEU2 marker. The YEpl3 library is a high copy library, while YCp50-LEU2 is a 
single copy library.
DNA Sequencing
All sequencing was done by the DNA sequencing facility at the University of 
New Hampshire
Electrophoresis of DNA
DNA was electrophoresed on agarose gels of 0.8 -  1.0% in TAE (Sigma) 
containing 0.75 pg/ml Ethidium bromide. A. DNA (New England Biolabs) cut with Hind 
m  was used as a DNA size marker.
Isolation of DNA from an Agarose Gel
A band was removed from an agarose gel with a razor blade in UV light. The 
band was placed in an Eppendorf tube and placed at -20°C overnight. The band was
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thawed and macerated with a pipet tip with its hole sealed by melting in a flame. This 
was transferred to a spin cartridge (company) and spun at 7,000 rpm in an Eppendorf 
tabletop centrifuge. Added to the resulting liquid was l/25lh volume 5 M NaCl and 2 
volumes ethanol. The pellet was washed with 70% ethanol. The dried pellet was 
resuspended in 8-10|ii sterile water.
Restriction Enzymes and Ligation Reactions
Restriction enzymes were obtained from New England Biolabs and Promega and 
were used as instructed with their accompanying buffers. Plasmid ligations were done 
using T4 DNA Ligase (New England Biolabs) and its buffer. When inserting fragment 
into a plasmid, a ratio of plasmid DNA to insert DNA of between 1:3 and 1:5 was used. 
When necessary, inappropriate self-ligation of plasmid DNA was prevented using Calf 
Intestine Alkaline Phosphatase (New England Biolabs) treatment.
PCR
PCR was performed using standard laboratory thermal cyclers. Each reaction 
contained template DNA combined with 0.2 mM dNTP mix, 1.5 mM MgCl2, 50 pmol of 
specific DNA primer and 1-5 units of Taq Polymerase in IX Reaction Buffer.
Program: 30 cycles - 94’C for 1.5 min, 43 °C for 1 min, 72 °C for 2 min.
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PCR Primers
1-42 KO primers
Primers designed for detecting disruptions in ASG2  were synthesized by 
Integrated DNA Technologies.
5’ Primer (1 -42KO-upper)
TAA TAG CGC ATA ATC TTG AA 
3’ Primer (1 -42KO-lower)
GGG GGA ATC CTC TAC AT 
Sequencing Primers
Primers used for sequencing inserts of genomic library clones were obtained from 
Sigma. These primers flank the BamHI site of the tetracycline gene present in pBR322, 
the plasmid from which genomic libraries used in this project were derived.
Preparation of Whole Cell Protein Samples for SDS-PAGE
2-10mls of overnight culture was harvested by centrifugation, and in some cases 
the cell pellet was frozen and stored at -80'C for use later. The pellet was washed with 
cold water, and resuspended in 250|Xl AL Lysis Buffer (0.5% SDS, 10 mM Tris pH 7.4,1 
mM EDTA) supplemented with protease inhibitors. Approximately 1 gram of clean glass 
beads (washed in nitric acid) was added and the sample was vortexed for 2 minutes at
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4°C. The sample was then boiled for five minutes and placed on ice for ten minutes. The 
sample was centrifuged briefly and added to an equal volume of 2X sample buffer (125 
mM Tris, 20% Glycerol, 2% SDS, 10pg/ml Bromophenol blue 2% (v/v) 2- 
mercaptoethanol, pH 6.8).
SDS-Polvacrvlamide Gel Electrophoresis
Protein extracts were separated on 7.5% polyacrylamide gels containing 0.1% 
SDS. Gels were polymerised using TEMED (Sigma) and Ammonium persulfate 
(Sigma). Electrophoresis running buffer contains 25 mM Tris, 192 mM Glycine, 0.1% 
SDS. Gels were run at 40-120 Volts in a Biorad gel system until the required degree of 
separation was achieved as indicated by the use of pre-stained markers (New England 
Biolabs).
Western Blot
Proteins were transferred from the gel to a membrane using a blotting tank 
(Biorad). The membrane was placed on top of 3 layers of Whatman blotting paper 
moistened with Transfer buffer (1.4% Glycine, 0.3% Tris, 0.04% SDS in 20% Methanol). 
The gel was placed on the membrane and 3 more moistened Whatman sheets are placed 
on top. The gel was blotted for at least 1 hour at 30 Volts.
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The membrane was incubated in Bovine-LactO Transfer Technique Optimizer 
(BLOTTO - 50mM Tris, 2mM CaCl2, 80mM NaCl, 5% Milk (from powder), 0.2% 
NP40) for Ihr on a shaking platform followed by incubation with the primary antibody 
for lhr (Ipg/ml in BLOTTO). The membrane was washed twice with PBST (PBS, 0.1% 
Tween 20) and twice with BLOTTO before incubation with the secondary antibody 
(lpg/ml in BLOTTO) for lhr. After four washes with PBST the membrane was 
incubated with chemiluminescent reagent (Pierce) chemiluminescence substrate for S min 
and quickly blotted to remove excess liquid. The membrane was placed in a cassette with 
a piece of X-ray film (Kodak). The film was developed manually by transferring the 
exposed film to developing solution (Kodak) for approximately 1 minute, followed by 1 
minute incubation in stop solution (Kodak) or water, and 10 minutes in fixer (Kodak).
A D R  Activity Gel
Native Cell Protein Extracts and Polyacrylamide Gel Electrophoresis
Native yeast extracts were obtained as described for SDS-PAGE in buffer lacking 
SDS and without the boiling step. These extracts were separated on 5% polyacrylamide 
gels prepared as described for SDS-PAGE, but lacking SDS.
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ADH Activity Staining
The native polyacrylamide gel was incubated for ten minutes with shaking at 
room temperature in 50mls of ADH  activity staining buffer (Img/ml NAD*, 80pg/ml 
phenazin methyl sulfate, 0.1 mg/ml nitro blue tetrazolium, 0.1% ethanol, 0.1 M Tris pH 
8.0) prepared immediately prior to use. The gel was washed in water until the yellow 
background was removed. Dark bands indicated the presence of ADH activity.
ADHTI assays
ADHH assays were performed by members of the Denis lab as previously 
described [Denis and Audino, 1991].
p-Galactosidase Assays
P-Gal assays were performed by members of the Denis lab as previously 
described [Cook et al., 1994].
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CHAPTER ID
RESULTS
A Genetic Screen for Suppressors of sptlO 
Determination of screen conditions
Strain 553-4b was chosen for a screen to isolate mutations that decreased the 
elevated ADH2 expression in the presence of glucose caused by an sptlO (gene name in 
lower case letters means mutant allele) mutation. Strain 553-4b contains an sptlO mutant 
allele called c re l- l , which allows partial release of ADH2 from glucose repression. 
Using the crel-l allele of SPT10 (gene name in capital letters means wild type or 
functional allele) has one significant advantage over disruptions of SPTIO. Deletions in 
SPTIO have a temperature sensitive phenotype, as well as slow growth on YD plates and 
8 mM caffeine plates. The crel-l allele results in none of these phenotyopes, therefore, 
screening in a crel-l background made it possible to test mutations that suppress sptlO 
for these other phenotypes directly. Screening in a sptlO deletion strain would require 
isolating said mutations into a strain that contained a functional SPTIO gene before 
determining if growth under these conditions is compromised specifically by the 
mutations identified in the screen.
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Strain 553-4b is known to be sensitive to 10 mM allyl alcohol. To test whether 
this concentration would be appropriate for this screen, YD plates containing S mM, 10 
mM, and 20 mM allyl alcohol were prepared. 553-4b grown on YD plates containing 8% 
glucose were replicated on to each of the three plates with different concentrations of 
allyl alcohol. It was important to grow strain 553-4b on YD plates with 8% glucose for a 
sufficient number of cell divisions to ensure that the ADH2 gene was fully repressed.
Strain 553-4b showed no growth on YD plates containing either 10 mM or 20 
mM allyl alcohol, and weak, but detectable growth on S mM plates at 30°C. Since it is 
important in such a screen to minimize the possibility of false revertants, S mM allyl 
alcohol was considered too low a concentration for this screen. 10 mM allyl alcohol was 
the chosen concentration for this screen because it was the lowest concentration that fully 
inhibited growth of strain 553-4b.
Spontaneous generation of mutations that suppress sptlO
Strain 553-4b was grown in YEP supplemented with 8% glucose. The density of 
this culture was not allowed to be over OD600=l.O to ensure that the cells remained 
glucose repressed. Approximately 1x10s cells were spread evenly onto ten YD plates 
containing 10 mM allyl alcohol. After three days, the first colonies began to appear. In 
order to ensure that the maximum number of possible mutations generated by this screen 
could be investigated, the plates were incubated for seven days. After seven days,
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thousands of colonies grew. The sizes of these colonies ranged from very large to very 
small.
Since it was not practical to further investigate every single colony generated 
from this screen, 317 total colonies were selected from six of the plates. Colonies of 
various sizes were purposefully selected in essentially equal numbers to minimize the 
chances of artificially selecting for certain types of mutations over others. These colonies 
were transferred to four YD plates containing 10 mM allyl alcohol with a toothpick. 
Each revertant was named with two numbers separated by a dash as a suffix to 553-4b, 
(for example, 553-4b-l-l), and was referred to by the last two numbers (l-l).
After four to five days of incubation on 10 mM allyl alcohol plates at 30°C, 119 
of the original 317 revertants showed either no growth or growth that was so weak that 
further analysis of them would not be possible. The remaining 198 revertants were 
transferred onto YD plates. A diagram of the process used to obtain a manageable 
number of revertants is presented in Figure 3.1.
Identification of Revertants Suitable for Further Analysis 
Elimination of mutations in the ADH2 structural gene
Since this screen selects for lack of ADH activity, mutations in the ADH2 gene 
itself would be expected to be produced by this screen. A nonfunctional ADH2 gene 
would, naturally, be unable to express a functional ADH2 gene product. By crossing a
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strain lacking a functional ADH2 gene to the revertants produced by this screen, adh2 
mutations could be identified by non-complementation.
Strain 43-2B-MI (a haploid) contains adhl-II and adh2-l alleles and is of the 
opposite mating type of strain 553-4b (also a haploid). Strain 43-2B-M1 was crossed to 
all 198 revertants and diploids were recovered. These diploids were grown in YEP liquid 
media supplemented with 3% ethanol. Any diploids containing ADH II activity would be 
able to grow, while adh2 mutants would not. After three days, 99 of the original 198 
showed very weak growth, while the other 99 showed very robust growth. The inability 
of the former 99 diploids to utilize ethanol as a carbon source indicates that the adh2 
defect in 43-2B-M1 was not being complemented.
To prove that the diploids with very weak growth were due to the lack of a 
functional ADH2 gene, the presence of ADH activity was assayed for directly. Native 
cell extracts were separated on a polyacrylamide gel and stained for ADH activity. Four 
diploids that grew well on ethanol were shown to have ADH activity and four diploids 
that didn’t grow on ethanol had no activity. Since the diploids being tested contained no 
functional ADHl gene, this proves that the lack of growth in ethanol containing media is 
a result of lack of ADH II activity, and, therefore, a functional ADH2 gene. The 99 
revertants that contained an adh2 mutation were discarded and the remaining 99 were 
kept for further analysis.
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Figure 3.1: Flowchart for Obtaining 25 Revertants for Further Analysis. 
A detailed description of this process can be found in the text.
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Phenotypic analysis of revertants
Since ccr4 and the other known suppressors of sptlO are sensitive to caffeine and 
a number of other factors such as high temperature and elevated salt concentration, the 
remaining 99 revertants were tested for sensitivity to these factors. Twenty-two of the 99 
showed sensitivity to one or more of the conditions tested. It was also observed that in a 
very general sense, these twenty-two showed overall better growth on 10 mM allyl 
alcohol plates than the revertants that were not sensitive to any of the conditions tested. 
The results of this phenotypic analysis are shown in Table 3.1. Three other revertants, 4- 
13, 5-32, and 5-37, showed weaker than normal growth on YD plates alone, and these 
same three showed exceptional growth on 10 mM allyl alcohol plates and sensitivity to 
Antimycin A. These three, along with the twenty-two revertants that showed some other 
form of growth defect were chosen for further analysis.
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553-4b . + ' + + + + -
553-4b-10 ++ - wk/+ wk/+ - . -
1-36 ++ - + + + + +
1-42 + + - + wk/+ - -
1-52 ++ - + + ++ + +
1-53 ++ - + + ++ + +
1-58 ++ - + + ++ + +
1-62 ++ - + + ++ + +
1-64 ++ - - + + + +
1-65 ++ - wk/- wk/- - - +
4-11 ++ - + + + + +
4-13 ++ + + + + + -
4-26 + - . - - - -
4-33 wk/+ - + + + + -
4-6 ++ . + + + + +
5-15 + - + + • + + +
5-17 + . - + wk/+ + +
5-21 + - + + + + +
5-32 ++ + + + + + -
5-34 + - + + + + -
5-37 ++ + + + + + .
5-84 ++ - + + + + +
6-16 + - + + + + +
6-22 + + . + wk/+ + -
6-39 + wk/+ + + wk/+ . -
6-58 + - + + + + +
6-72 + - + + + wk/+ -
Table 3.1: Phenotypes of the 25 Revertants Studied in This screen.
All incubations were done at 30°C unless otherwise specified. Phenotypes scored as 
wk/+ are considered to not be sensitive, but it was noted that growth was weaker than the 
parent strain. Similarly, wk/- means that strains were scored as sensitive, but after 
sufficient length of incubation very weak growth was observed.
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Of the 22 revertants that were sensitive to one of the factors tested, 19 were 
caffeine sensitive. This is by far the most common phenotype observed in this screen, 
although it should be noted that the vast majority of revertants were not sensitive to any 
of the conditions tested. A temperature sensitive (TS) phenotype was observed in six 
revertants, two of those in strains not sensitive to caffeine, 1-42 and 6-22. Cold 
sensitivity (CS) was found in only two revertants, 1-65 and 4-26. These two revertants 
were also caffeine sensitive and TS, as well as sensitive to 0.75 M MgCU and 0.2 M LiCI, 
making them the only two revertants sensitive to all of the conditions tested. Two other 
revertants, 1-42 and 6-39, were lithium sensitive, and none of the other revertants were 
magnesium sensitive.
Surprisingly, fourteen of the revertants showed an increased resistance to lithium. 
These revertants could grow at 0.3 M LiCI, whereas 553-4b could not. Four of these also 
showed noticeably better growth on 0.75 M MgCL plates. All fourteen were also 
sensitive to caffeine, further indicating that they potentially belonged to a group of 
similar mutations.
None of the components of the CCR4-NOT complex show resistance to increased 
lithium concentration when mutated. Therefore, this group may represent a gene or 
genes that act in a different manner than Ccr4p. While it is not possible to identify a 
specific process or pathway that is being affected by caffeine, temperature, or salt 
concentration, these sensitivities indicate a more global effect of these mutations beyond
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affecting ADH2 expression. Mutations in CCR4-NOT complex components result in 
multiple sensitivities to many different conditions, attesting to their widespread effects on 
gene expression. For this reason, it was of particular interest that five of the revertants 
generated in this screen, 1-65,4-26,1-42,5-17, and 1-64 were sensitive to two or more of 
the conditions tested.
Further Analysis of Remaining Revertants 
ADH II activity in the revertants are reduced
ADH II activity assays were conducted on the remaining 25 revertants, the parent 
strain 553-4b, and 553-4b-10, which contains a ccr4-l0 allele. The results are described 
in Table 3.2. The ADH Q assay values obtained confirm that growth on allyl alcohol is 
due to reduced expression of ADH2. As expected, values for many of the revertants were 
not as low as the ccr4 strain 553-4b-10. Accordingly, many of the revertants identified 
were not Antimycin A sensitive. On glucose, most showed at least a two-fold reduction 
of ADH II activity compared to 553-4b. This is further evidence that these mutations are 
in genes that are required for normal ADH2 expression.
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Table 3.2: ADH n  Activity Assays of the 25 Revertants Studied in This Screen.
Values are averages of three separate assays in both glucose and ethanol containing 
media. Standard errors for all values are less than 20%.
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Assay values for these revertants grown in ethanol medium showed a wide range 
of values. Two mutants, 5-32 and 5-37 have values of under 100, over a twenty-fold 
reduction compared to the parent strain. Some had very minor effects, if any, having 
values of about 2000. Most of the activity levels in these revertants fell into an 
intermediate range around 1000, with thirteen activities between 500 and 1400. This 
would indicate that there were a number of different genes produced by this screen. It 
was likely, however, that different alleles of the same gene could result in different 
activity levels.
Based on these values, it was not possible to place many of these revertants into 
groups. However, 5-32,5-37, and 4-13 were of particular interest due to their very low 
activities on ethanol and their phenotypic similarity, and were considered likely to be 
related, if not mutations in the same gene. It was of interest that these three revertants 
were the three selected for further analysis despite the fact that they were not sensitive to 
any of the conditions tested in the phenotypic analysis described above.
Identification of known suppressors of sat 10 hv complementation
To test if any of the revertants generated in this screen were ccr4 mutations, a 
western blot was done. Cell extracts of all 25 revertants as well as the parent 553-4b and 
553-4b-10 were prepared, run on a  gel, and probed with CCR4 antibody. Extracts from 
only one revertant, named 1-65, lacked detectable Ccr4p. In order to confirm this
54
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
identification, and to determine if any of the other revertants were due to point mutations 
that would compromise the function of CCR4, but not affect its expression or 
immunoreactivity, strain 1076-2c was crossed to all of the revertants. Diploids were 
obtained and tested for caffeine sensitivity. Only I-65 failed to grow on caffeine. This 
confirms that 1-65 is a ccr4 mutation and that none of the other revertants are defective in 
CCR4 function.
Similarly, strain 1005-2-3c-s was crossed to all revertants to test for ca fl 
mutations. 1005-2-3c-s contains cafl::LEU2 and sptlOv.TRPl knockouts. The strains 
were crossed and diploids were obtained and grown on 10 mM allyl alcohol plates. Any 
revertants containing a functional CAFl gene would have an sptlO phenotype and would 
not grow on allyl alcohol, while revertants containing ca fl mutations would not 
complement and would grow on allyl alcohol. Twenty-one of the 25 revertants did not 
grow on 10 mM allyl alcohol. Of the remaining four, the results were inconclusive. 4- 
13,4-26,6-39, and 6-72 all showed weak or spotty growth on 10 mM allyl alcohol. This 
weak growth was not considered strong enough to definitively place these four in a 
complementation group with CAFL
1-65 is one of the four revertants that were sensitive to more than one of the 
conditions tested, and the phenotypes of 1-65 are consistent with other known mutations 
of CCR4. Interestingly, 1-65 is aTS allele of CCR4, while all other mutations in CCR4 
to date have either not been TS or at least grew weakly. Of the possible CAF1 revertants,
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4-13 seemed unlikely to be a cafl allele. 4-13 is not sensitive to any of the conditions 
tested, whereas cafl strains are sensitive at least partially to all of these factors. Although 
each are phenotypically different, all of the other three display at least mild sensitivity to 
two or more factors, and could conceivably be cafl alleles.
Identification of complementation groups in remaining revertants
In order to further classify the remaining revertants, MAT a  versions of six 
revertants (4-6, 1-42, 5-17, 4-33, 6-72, and 5-37) were created, and the six new strains 
were named BA1-1 through BA6-1. These six revertants were selected for their 
apparently different phenotypes and ADH II activity. Revertant 4-6 was one of the 
fourteen revertants that was resistant to 0.3 M LiCI, and revertants 1-42 and 5-17 were 
two of the remaining revertants with multiple sensitivities. Revertants 4-33 and 6-72 
were both caffeine sensitive with differing ADH II activities, 6-72 being one of the 
revertants that grew weakly when crossed with the cafl strain 1005-2-3c-s. Finally, 
revertant 5-37 belonged to the class of revertants with severely compromised ADH It 
activity when grown on ethanol containing media. The results of the analyses of these 
strains are summarized in Table 3.3.
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Strain 43-2B crossed with Relevant Genotype
BAl-l 4-6 MATa adhl-l 1 leu2 asgl-4-6
BA2-1 1-42 MATa adhl-l 1 leu2 his4 asg2-l-42
BA3-1 5-17 MATa adhl-l I leu2 asg3-5-l7
BA4-1 4-33 MATa adhl-l I leu2 trpl asg4-4-33
BA5-1 5-37 MATa adhl-l 1 leu2 trpl asg5-5-37
BA6-1 6-72 MATa adhl-l 1 trpl asg6-6-72
Table 3.3: Mating Type a  Strains Generated for Complementation Group Analysis.
Strain BA 1-1 was crossed to all revertants and diploids were obtained. These 
diploids were tested for caffeine sensitivity. As expected, the diploid resulting from the 
cross of strain B A l-l and 4-6 was caffeine sensitive. In addition, nine other diploids 
showed caffeine sensitivity, grouping these ten revertants into the same complementation 
group. This process was repeated with strains BA2-1 through BA6-1. Crosses with 
strain BA2-1, containing the 1-42 mutation, were tested for complementation at 37°C, 
and crosses with strain BA5-1, containing the 5-37 mutation, were tested for 
complementation on allyl alcohol. All other crosses were tested for complementation on 
caffeine plates.
No other members of the complementation groups represented by strains BA2-1 
through BA6-1 were found using this method. All of the mutations produced by this 
screen were shown to be recessive, as all of the revertants were complemented when 
crossed to at least five o f the other mutations. The six genes defined by the
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complementation groups were named ASG genes (Allyl alcohol phenotype Suppressing 
Gene). For convenience, the alleles were named with the numbers that were previously 
associated with the mutation. For example, the mutation in revertant 4-6 was named 
asgl-4-6. The results of this complementation group study are summarized in Table 3.4.















2 BA2-1 TS 1-42 asg2-l-42
3 BA3-1 Caffeine 5-17 asg3-5-17
4 BA4-1 Caffeine 4-33 asg4-4-33
5 BA5-1 Antimycin A 5-37 asg5-5-37
6 BA6-1 Caffeine 6-72 asg6-6-72
adh2 43-2B-MI Growth on 99 NA
Ethanol Revertants
ccr4 I076-2c Caffeine 1-65 ccr4-l-65
cafl Determined by cloning 4-26 cafl-4-26
Table 3.4: Complementation Groups Found in This Work.
It was noted that using this method, revertant 6-72 was found to be in a 
complementation group of its own. In an earlier cross testing for mutations in CAF1,
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revertant 6-72 was scored as potentially containing a cafl mutation. The reason for this 
apparent partial non-complementation is not known. The cross used to test for cafl 
mutations was done in an sptlO background, and due to the sptlO null allele present in 
strain l005-2-3c-s, caffeine and temperature sensitivity could not be used for 
complementation purposes. Therefore, the test for cafl complementation was done on 
allyl alcohol plates. A mild synthetic phenotype resulting from only having one copy of 
each of these genes could possibly explain the weak growth observed on allyl alcohol 
plates. The search for complementation groups using strain BA6-1, which contained the 
6-72 mutation, was done using the caffeine sensitive phenotype. As the caffeine sensitive 
phenotype had proved itself to be a more reliable phenotype to follow through different 
strain backgrounds, it was concluded that 6-72 was indeed in its own complementation 
group.
Identification of Genes Involved in ADH2 Expression 
It was of great interest to determine which genes were mutated in the revertants 
generated by this screen. The parent strain, and, therefore, all of the revertants, contained 
a leu2 mutation which was exploited to transform a LEU2-containing yeast genomic 
library into selected revertants. A plasmid containing a functional copy of the mutated 
gene responsible for sptlO suppression could then be isolated and the gene identified.
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Identification of ASG2. a new gene involved in ADH2 expression
Strain 553-4b-l-42 was transformed with a YEpl3 high copy yeast genomic 
library. Approximately 15,000-20,000 colonies grew after five days on Synthetic 
Complete plates lacking Leucine (SC Leu* plates). The transformants were replica plated 
to SC Leu* plates and placed at 37°C. This process was done in two steps because 
previous experiments attempting to grow cells directly at 37°C produced no colonies. In 
order to ensure that a sufficient number of transformants were expressing the plasmid, it 
was necessary to do this in two steps.
After 4-5 days of incubation at 37°C, a single revertant clone was identified. This
colony was transferred to a SC Leu* plate and incubated at 37°C for another 3 days. This 
was done to avoid accidental transfer of neighboring cells that may not be able to grow at 
37°C, but happened to survive the initial incubation. The transformant was then
transferred to an SC Leu* plate for further analysis. The plasmid that the transformant 
contained was named 1-42-1.
Plasmid dependency was determined as described in the Materials and Methods
section. Loss of plasmid, as tested by loss of the ability to grow on SC Leu’ plates, 
resulted in the loss of ability to grow at 37°C. In order to confirm this, the transformant
was transferred to an SC Leu* plate supplemented with 10 mM allyl alcohol (A.A.). 
Strains 553-4b and 553-4b-10 containing YEpl3 with no insert were used as controls.
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The transformant was unable to grow on SC Leu~ 10 mM A.A., showing that the plasmid 
also complemented the sptlO  suppression phenotype of asg2-I-42. This strongly 
suggested that the plasmid contained a functional ASG2 gene.
Plasmid 1-42-1 was rescued from yeast and transformed into DHS-alpha E. coli 
cells. The plasmid was then prepared from E. Coli and digested with Pstl. Yep 13 alone 
contains a 4.1 Kbp Pstl fragment, and testing for the presence of this fragment was done 
to confirm that the plasmid rescued was YEpl3 based. This band was detected in 1-42-1 
digests. This plasmid was transformed into strain 553-4b-l-42 to re-test for 
complementation. The resulting transformants were able to grow at 37°C and were allyl 
alcohol sensitive, confirming that this plasmid was responsible for the complementation 
observed.
Plasmid 1-42-1 was sequenced in two places flanking the BamHI site of YEpl3 
where the insert was cloned. The completion of the sequencing of the yeast genome 
makes it possible to analyze and obtain large sequences of genomic DNA after 
determining such flanking sequences. The resulting sequences were compared to the 
yeast genome sequence on the SGD website, and were found to surround a 4.3 Kbp 
region of chromosome IV. This region, which was the insert of 1-42-1, contained a 
single gene identified as YDR206w, which was named ASG2 in accordance with the
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name given to the 1-42 mutation in the complementation group study. The full sequence 
of the insert was obtained from the SGD website.
Three Ncol sites were found to exist within the ASG2 gene that were the only 
Ncol sites on plasmid 1-42-1. These fragments were removed by Ncol digestion and 
subsequent religation of the linearized plasmid. The resulting plasmid contained an in 
frame deletion of amino acids 456-783 of ASG2 (see Figure 3.2). Transformation of this 
new plasmid, 1-42-l-ANcol, into revertant 1-42 produced colonies that failed to grow at 
37°C. This proved conclusively that the ASG2 gene on the plasmid was responsible for 
the effects observed in strain 533-4b-l-42.
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Figure 3.2: ASG2 Plasmids
1. 1-42-1, the YEpl3 genomic clone. Shown is the 4311 bp insert containing ASG2, 
which is represented by a gray box. Relevant restriction sites are shown.
2. 1-42-1-ANcoI. Digestion of 1-42-1 with Ncol liberates nucleotides 1802-2788 of the 
insert. Religation resulted in an internal in-frame deletion of amino acids 456-783 of 
the predicted protein sequence of ASG2.
3. 1-42-KO. The fragment defined by the internal Hindm site and an EcoRI site present 
in YEpl3 on the 5' side of the insert was subcloned into pUC!8. Subsequently, the 
URA3 gene was cloned into the BglII site in the 5' end of ASG2.
4. LexA-l-42. The fragment defined by the BglU site in the 5' end of ASG2 and a Sail 
site in YEpl3 on the 3' side of the insert was subcloned into plasmid 202-2 to create 
an in-frame LexA-Asg2p fusion construct.
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Identification of ASG3/LSM6
Revertant 5-17 was transformed with the yeast genomic library YEpl3. A 
procedure similar to the one used in the cloning of A SG2 was used to obtain three 
transformants that were caffeine resistant Only one of these colonies was shown to be 
plasmid dependent by the methods previously described. This transformant was also 
unable to grow on SC Leu- 10 mM allyl alcohol media, indicating that the plasmid, 
named 5-17-1, truly complemented the asg3-5-l7 mutation. Plasmid 5-17-1 was rescued 
from yeast, transformed into E. coli, and DNA was prepared. PstI digestion revealed the 
4.1 Kbp fragment of YEpl3. Sequences flanking the insert were obtained and analyzed 
on the SGD website.
The insert of 5-17-2 was a 6.5 Kbp fragment of chromosome IV containing three 
genes, ATP17, LSM6, and RGA2. RGA2 has been described as a GTPase activating 
protein, LSM6 is believed to be involved in RNA splicing and processing, and ATP 17 is a 
subunit of ATP synthase. None of these genes initially appeared likely to be involved in 
Ccr4p-like regulation of ADH2, but atp!7  mutants are unable to utilize nonfermentative 
carbon sources, as is revertant 5-17. A BamHI-Sall fragment of plasmid 5-17-1 that 
contains ATP17 and LSM6 was subcloned into pRS315. pRS315 is a single copy plasmid 
with containing a LEU2 gene. This plasmid was able to complement the caffeine 
sensitive phenotype of 5-17, showing that one of these two genes, but not RGA2, is 
responsible for this complementation.
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YCp50-LEU2, a single copy yeast genomic library, was also transformed into 5- 
17 and a single caffeine resistant colony was obtained by the methods previously 
described. This effect was shown to be plasmid dependent. Sequencing of this plasmid 
showed that ATP 17 and LSM6 were contained within the insert. This supports the earlier 
experiments showing that either ATP 17 or LSM6 complements the asg3-5-l 7 mutation.
In order to clarify this situation, an lsm6 strain, AEMY19, was obtained from Dr. Jean D. 
Beggs of the University of Edinburgh. Strain 5-17 was crossed to AEMY19, and the 
resulting diploid strain was grown on 8 mM caffeine plates and at elevated temperature. 
The diploid failed to grow completely in the presence of 8 mM caffeine and grew only 
weakly at 37°C. This failure to complement indicates that the asg3-5-17 mutation is an 
allele of lsm6.
4-26 contains a cafl mutation
4-26 was selected to be transformed with a genomic library in an attempt to clone 
the gene responsible for sptlO suppression. 4-26 has significantly lowered ADH2 activity 
and severe growth defects, and was identified as possible containing a cafl mutation. A 
YCp50-L£t/2 genomic library was transformed into 4-26. By the described procedures, 
one caffeine resistant colony was obtained and was selected for further analysis. Plasmid 
dependency was confirmed and the plasmid was rescued from yeast and transformed into 
E. coli. Retransformation of the plasmid into 4-26 once again restored the ability to grow
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on caffeine, supporting the earlier plasmid dependency test. PstI digestion revealed the 
characteristic 4.1 Kbp fragment of the LEU2 plasmid.
The plasmid was sequenced and analyzed using the described protocol. The 
insert was a 5-7Kbp fragment of chromosome XIV containing CAF1 and a hypothetical 
ORF named YNR053c. Little is known about YNR053c other than that it is an essential 
gene. The possibility that YNR053c is responsible for the sptlO suppression observed 
exists, but given that the asg4-4-26 mutation has already been shown to exhibit very 
limited complementation with a cafl allele, it was concluded that strain 4-26 contains a 
cafl allele.
Identification of ASG6/NUP1S9
Strain 6-72 was transformed with the YCp50-LEU2 genomic library. By the 
methods previously described, a single colony was obtained that was able to grow on SC 
Leu* 8 Mm caffeine plates in a plasmid dependent manner. The plasmid, named 6-72-1, 
was sequenced and was shown to contain an 8.4 Kbp fragment of Chromosome IX. 
Three genes were identified that could potentially be responsible for sptlO suppression, 
YIL113w, POR2 and NUP159.
YIL113w is a putative protein tyrosine phosphatase, POR2 is an anion channel 
protein, and NUP159 is on the cytoplasmic side of the nuclear pore complex involved in
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mRNA transport. Given the function of NUPI59 and that a defect in such a gene could 
result in lowered gene expression, a nupl59 strain was obtained from Dr. Charles Cole at 
Dartmouth University. The strain, LGY101, contains the rat7-l mutation, an allele of 
NUP159.
LGY101 was crossed to strain 6-72. The resulting diploids failed to grow on 8 
mM caffeine plates, indicating that the asg6-6-72 mutation could not complement the 
rat7-l mutation. Furthermore, when plasmid 6-72-1 was transformed into LGY101 it 
restored the ability of LGY101 to grow on 8 mM Caffeine in a plasmid dependent 
manner. This demonstrates that asg6-6-72 is an allele of NUP159.
Further Analysis of ASG2 
Analysis of disruptions in ASG2
In order to analyze the effects of an asg2 mutation in different strain backgrounds, 
asg2::(JRA3 disruptions were generated in a number of different strains. To test the 
interaction between ASG2 and SPT10, disruptions were generated in strains 994-2, 
DY3462, and DY3462-slO-2. To investigate the more general effects of ASG2, 
disruptions were made in strains 612-Id and EGY188. All disruptions were made by 
transforming strains with plasmid 1-42-KO that had been digested with EcoRI and Sail 
restriction enzymes (see Figure 3.1). The results of phenotypic analysis of these 
disruptions are presented in Table S.
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553-4b . + + - + + - -
1-42 + . . . + + - -
994-2 . + + - wk/+ + - -
994-2-AASG2 + . - - wk/+ + - -
612-ld ND + + + + + wk/+ +
612-ld-AASG2 ND - - - - wk/+ - -
EGY188 ND + + + + + + +
EGY188-AASG2 ND + + + + + + +
Table 3.5: Phenotypes of an asg2::URA3 Disruption in Various Strains.
All incubations were done at 30°C unless otherwise specified. Phenotypes scored as 
wk/+ are considered to not be sensitive, but it was noted that growth was weaker than the 
parent strain.
Strain 994-2 contains an sptlO::TRPl disruption. An asg2::URA3 disruption was 
generated in strain 994-2 and the resulting strain was named 994-2-AASG2. 994-2- 
AASG2 cells were temperature sensitive and allyl alcohol resistant, while the parent was 
allyl alcohol sensitive, and grew, albeit weakly, at 37°C. Growth on 0.2 M LiCl plates 
was also tested, and a asg2::URA3 disruption in strain 994-2 resulted in lithium 
sensitivity. These phenotypes correlate exactly with the phenotypes of 1-42. Strain 994- 
2 grew poorly on caffeine plates, and the asg2 disruption had no effect on this growth. 
The fact that asg2 could suppress sptlO when both genes are disrupted shows that this 
interaction is not allele specific.
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Strain 612-ld contains an adhl-11 allele, and strain EGY188 is essentially a wild 
type strain except for a LEU2 gene that is under the control of LexA operators for use in 
two hybrid experiments. Temperature and lithium sensitivity were observed in strain 
612-ld-AASG2, where the parent strain, 612-ld, exhibited wild-type growth. 
Disruptions of asg2  in strain 612-ld were also unable to grow at 37°C on 
nonfermentative media. Strain 1-42 had a weak defect in growth on 0.7S M MgCl2 
plates. Strain 612-ld-AASG2 also grew weakly relative to the parent on 1.0 M and 0.75 
M MgClj plates. Why magnesium had no effect on strain 994-2-AASG2 is unclear, but 
strain background is known to influence phenotypes, and comparisons between such 
weak phenotypes in different stains must take this into consideration. Interestingly, 
compromised growth on caffeine was observed in strain 612-ld-AASG2 that, like the 
Mg2* phenotype, is not present in other backgrounds.
In the wild type strain EGY188, an asg2::URA3 disruption had no effect on any of 
the conditions tested. Growth on 0.3 M LiCl plates and on YD plates at 39°C was also 
tested and the asg2::URA3 disruption had no effect. The lack of effect of asg2 in strain 
EGY188 is not considered to be merely due to strain background, but rather the presence 
of ADH1. The presence of AD H I could compensate for these defects by allowing 
generally better growth.
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To test the effects of an asg2::URA3 disruption, disruptions were made in strains 
DY3462 and DY3462-slO-2. At 25°C, strain DY3462 does not grow on media lacking 
histidine, while this phenotype is suppressed by sptlO in strain DY3462-slO-2. An 
asg2::URA3 disruption in strain DY3462 gives no spt phenotype itself, but in strain 
DY3462-slO-2, the asg2::URA3 disruption suppresses the spt 10 phenotype at the his9l2- 
8 locus. This shows that the relationship between ASG2 and SPT10 is not limited to their 
effects on ADH2.
If Asg2p functioned solely to regulate ADH2 expression, its effects would have 
been expected to be restricted to the ADH2 gene. The fact that asg2 mutants could 
suppress sptlO at both ADH2 and the his4-9l28 locus suggests a global role for Asg2p in 
transcription. SptlOp has been implicated in histone regulation, and its effects on 
promoters are believed to be due to lack of proper nucleosome formation. For a gene like 
ASG2 to overcome this defect, it is unlikely that it has specific roles at both ADH2 and 
HIS4. Asg2p likely belongs to a class of proteins whose function affects transcription 
generally.
LexA-ASG2 Interactions in the Two.Hvbrid System
To test for interactions between Asg2p and other components of the CCR4 
complex, a  plasmid encoding a LexA-ASG2 fusion protein (LexA-1-42) was created.
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The plasmid was transformed into strain EGY188 containing the p34 reporter plasmid. 
Strain EGY188 contains a LEU2 gene under the control of the LexA operator sequence, 
hence, growth on SC plates lacking Leucine is evidence for activation of transcription by 
a LexA fusion protein. Plasmid p34 contains eight concatenated LexA operator 
sequences in the promoter of a LacZ gene, and blue color on X-Gal plates is used as 
evidence for activation. The LexA-ASG2 fusion on its own was not able to activate 
transcription by either plate assay. The EGY188 strain containing LexA-1-42 was 
crossed to EGY191 strains containing numerous different B42 fusions. The resulting 
diploids were analyzed for interactions on X-gal plates. Eight diploids turned a very light 
blue color.










Table 3.6: p-Galactosidase Assay Values.
LexA-Asg2p interactions with the B42 fusions listed were assayed three times and 
average values are presented. Standard errors of all values are less than 20%.
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The results of assays done on these eight diploids are shown in Table 3.6. None 
of these interactions were particularly strong. The three interactions of over 100 units 
were with the proteins Not2p, Asclp, and MptS. Not2p is part of the CCR4 complex, 
Asclp appears to function in translation, and MPT5 was identified as a suppressor of 
cafl, and is involved in telomere maintenance and mRNA degradation.
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CHAPTER IV
DISCUSSION
In this screen, a number of genes were identified that were able to suppress the 
effects of an sptlO mutation on ADH2 expression. As expected, mutations in the known 
suppressors ADH2, C CR4 , and CAFl were identified. Three new genes were also 
identified, ASG2/EBS1, ASG3/LSM6, and ASG6/NUPI59 that suppressed sptlO at ADH2.
A General Discussion of the Screen
The Effectiveness of the Stran
The previous screen by Denis [1984] placed an Antimycin A sensitivity 
requirement on revertants to sptlO that was not utilized in the screen described in this 
work. The lifting of this requirement allowed for the identification of a larger group of 
mutations. Accordingly, a substantially larger group of revertants were obtained, only a 
subset of which could be reasonably investigated. The identification of CAFl in this 
screen, which was not identified in the previous screen, is evidence that the approach 
undertaken has merit and could indeed return relevant information that was not obtained 
in the Denis [1984] screen. Nevertheless, the absence of NOT4, DBF2, SRB9, and SRB10
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should be explained, as their absence suggests that the screen was not saturated, that is, 
not all possible mutations capable of suppressing sptlO atADH2 were identified.
Deletions of SRB10 and SRB9 do not have any of the phenotypes tested for in the 
phenotypic analysis phase of this work, and for that reason would not be expected to be 
represented in the 25 revertants that were analyzed. dbf2 mutants are weakly TS and 
weakly caffeine sensitive. There is a possibility that mutations in dbf2 were indeed 
generated in this screen, but if these mutations did not substantially compromise growth 
at elevated temperature or on caffeine, they would not have been selected. During the 
phenotypic analysis, only revertants with strict no-growth phenotypes on at least one 
growth condition were selected for further analysis. One reason that this requirement was 
used is that such phenotypes were to be exploited in complementation analyses and as a 
means for cloning by complementation. Weak growth was not considered sufficient for 
these purposes.
Strains containing mutations in SRB9, DBF2, NOT I, and NOT4 were crossed to 
the revertants for complementation purposes. The lack of a suitable srblO strain did not 
permit its inclusion in this analysis, but, as indicated, it was not expected to be 
represented in the 25 revertants because it lacked any relevant phenotypes. None of the 
revertants were found to contain srb9, d b f  2, or notl mutations, nor did any of the 
revertants contain mutations in NOT4, with one notable exception.
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The product of the cross between a not4 strain and revertant 5-32 was a diploid 
that failed to grow on 8 mM caffeine plates. This might indicate that revertant 5-32 
contains a not4 mutation, however, this result is inconclusive. On 8 mM caffeine 
revertant 5-32 is not normally sensitive, but the diploid shows no growth at all. 
Additionally, the not4 strain is TS, while revertant 5-32 is not, and neither is the diploid. 
The confusion would be best clarified by western analysis of revertant 5-32 using NOT4 
antibody. Conclusive results of such an experiment are not yet possible due to the lack of 
a NOT4 antibody with sufficient specificity.
Issues with Cloning bv Complementation
Cloning by complementation was ultimately successful in identifying four genes, 
CAFI, ASG2, ASG3/LSM6, and ASG6/NUP159. It should be noted that repeated attempts 
to clone other revertants by this process were also conducted. During the course of this 
work, revertants 1-36, 1-64, 4-6,4-11, 5-37, 6-16, and 6-22 were all transformed with 
genomic libraries. The results of these transformations were unsuccessful, and in many 
instances the reasons for this are unclear.
The transformation of revertant 5-37 was unlike any of the others in that it was 
necessary to test for complementation on Antimycin A plates. The transformation 
resulted in a  large number (hundreds) of transformants that complemented the sensitivity 
of revertant 5-37 to Antimycin A. The obvious barrier to clarity in this instance is the
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knowledge that ADH genes would likely result in the ability to grow on Antimycin A. 
With no simple, reliable method to distinguish ADH genes from the gene that is 
complementing the asg5 mutation in revertant 5-37, it was decided not to proceed.
Transformations of genomic libraries into the other revertants failed to return 
positive transformants. In certain instances, poor transformation efficiency may have 
been a factor, but this cannot account for the majority of these transformations. The 
genomic library, while having been successful on five similar occasions, was not beyond 
suspicion, but was not likely the sole reason for the lack of success in these other 
attempts to clone genes.
Every single one of these six other revertants was transformed with a genomic 
library at least two times, with revertant 1-64 being transformed at least four times, and 
revertant 4-6 no less than twelve times. Considering that revertants 1-36,4-6, and 4-11 
all belong to the same complementation group, it is questionable whether this technique 
would ever prove successful in cloning ASG1. It should be noted here that there were 
two genomic libraries used in these experiments, YEpl3, a multiple copy genomic 
library, and YCp50-LEU2, a single copy genomic library, both having been used 
approximately half of the time.
Both of the libraries used in these transformations were created by partial 
digestion of the yeast genome with the restriction enzyme Sau3AI. The resulting 
fragments were then cloned into the BamHI site in the selected vector. Sau3 AI has a four
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base pair recognition sequence that occurs frequently in the genome, which returns a 
better representation of the genome in the created library than if the genome were 
digested with BamHI.
It is possible that if a gene were rich in Sau3AI restriction sites the gene would 
not be represented well in the library because it would be rare for an uncut version of the 
gene to remain after digestion. Conversely, if a gene was located in a region that contains 
very few Sau3AI restriction sites, it is also likely to be underrepresented in the library due 
to the fact that many of the fragments that contain the gene are prohibitively large.
Another independent issue involves the representation of very large genes in 
genomic libraries prepared by this method. Large genes are inherently more likely to 
contain more Sau3AI restriction sites, which makes it less likely that a full length 
functional version of the gene is represented in the library. Additionally, a larger insert 
means a larger plasmid, and upon amplification in a genomic library, large plasmids are 
replicated more slowly and become even more rare. This effect multiplies the difficulty 
of representing large genes in genomic libraries.
It is possible that ASGI is a very large gene. It is also possible that the gene is not 
represented in either library at all. The number of transformants screened is too great to 
assume that screening an ever larger number of colonies that ASGI would eventually be 
cloned by complementation using standard genomic libraries. This is unfortunate, as 
ASGI mutations represent 40% of all revertants selected for analysis in this screen.
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While revertants 1-64,6-16, and 6-22 were not transformed as many times as the ASGI 
complementation group, it is possible that some of the factors discussed were hampering 
progress in these revertants as well.
Genes Cloned in This Screen
The identification of CAF1 in this screen proved that the identification of CCR4- 
NOT complex components other than CCR4 was possible using this method. Caflp had 
previously been shown to be a component of the CCR4-NOT complex, sharing 
significant functional similarity with Ccr4p. The other genes identified in this screen, 
ASG2/EBS1, ASG3/LSM6, and ASG6/NUPI59 had not previously been associated with 
CCR4 or ADH2. Given what was known about these genes, none of the three seemed 
likely to be components of the CCR4-NOT complex. ASG2 has sequence similarity to a 
telomerase, ASG3ILSM6 is involved in RNA processing and degradation, and 
ASG6/NUP159 is a nuclear pore component involved in mRNA transport.
Biochemical analysis of the CCR4-NOT complex was conducted in asg2, asg3, 
and asg6 strains. It was shown that strains lacking either of the three genes had no effect 
on any of the components or their stoichiometry [P. Russell, Pers. Comm.]. With the 
knowledge that Ccr4p function has been shown to be linked with the CCR4-NOT 
complex, it was concluded that ASG2, ASG3, and ASG6 must be functionally separated
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from Ccr4p. This does not, however, necessarily exclude the possibility that these genes 
function in the same pathway as CCR4.
Recently, CCR4 and CAF1 were shown to encode components of the cytoplasmic 
deadenylase in yeast [Tucker et al., 2001]. Mutations in CCR4 and CAF1 result in 
reduced deadenylation rates and the extent of deadenylation of reporter transcripts. This 
reduced extent of deadenylation does not permit decapping, leading to accumulation of 
capped oligoadenylated mRNA. The consequences of these defects as to how they relate 
to the previously reported interactions between CCR4 and CAF1 with transcription 
factors are still unknown. The clarification of these genes' functions in both transcription 
and mRNA turnover is an anticipated result of further experimentation.
ASG6/NUP159
At the time of identification in this screen, NUP159 was the best characterized 
gene of the three. NUP159 is an essential gene whose product is known to be a 
component of the nuclear pore complex responsible for mRNA export. Mutations in 
NUP159 result in accumulation of mRNA in the nucleus and decrease in protein 
synthesis [Gorsch et al., 1995]. The proposed model for reduced ADH2 expression in 
revertant 5-17 is that it is a  result of the failure to export ADH2 mRNA due to the asg3-5- 
17 (nup!59) mutation.
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A SG 3/LSM
LSM6 is one of a group of eight genes, LSMI-LSM8, which share similarity to the 
Sm genes involved in RNA processing in eukaryotes [Mayes et al., 1999]. These Sm 
genes are the core spliceosomal snRNPs involved in RNA processing. In yeast, a 
complex containing the yeast Sm genes is well known to bind snRNAs in the context of 
the spliceosome. The identification of the Sm motif, a conserved sequence present in Sm 
proteins led to the discovery of Sm-like sequences in other genes. These Sm-like genes 
were named LSM genes (Like Sm).
A nuclear complex comprising Lsm2p-Lsm8p was shown to be associated 
specifically with a single snRNA, U6, and was required for its stability. Further studies 
revealed a second complex comprising Lsmlp-Lsm7p that was involved in RNA 
turnover. This second complex localized to the cytoplasm, and was required for 
decapping of mRNA [Bouveret et al., 2000].
Specifically, the stability of the U6 snRNA was reduced in lsm6 mutants. The 
temperature sensitive phenotype of lsm6 could also be rescued by overproduction of U6 
snRNA, suggesting that U6 snRNA depletion is responsible for temperature sensitivity in 
lsm6 strains. LSM6 has also been shown to be required for proper mRNA degradation in 
the context of the cytoplasmic Lsmlp-Lsm7p complex. Degradation of reporter mRNA 
in lsm6 strains is 2.0-2.5 fold slower than in wild type strains, and accumulation of 
oligoadenylated full-length capped mRNA occurs in lsm6 strains [Bouveret et al., 2000].
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Interestingly, this phenotype is remarkably similar to observations made in ccr4 
and cafl strains. Both studies used the same reporter transcripts, MFA2pG and PGKlpG, 
which have been well characterized in mRNA degradation assays. Ism6 strains appear to 
be defective in decapping, and ccr4 and cafl strains cannot sufficiently deadenylate 
mRNA to allow decapping. Both of these scenarios result in accumulation of capped 
oligoadenylated mRNA. A model of how this may affect ADH2 mRNA levels is 
described below.
Given that the mechanism by which the asg3~5-l7 mutation suppresses sptlO 
likely occurs after the production of mature ADH2 mRNA, due to the fact that ADH2 
contains no introns, it is unlikely that the lack of Lsm6p in the nuclear LSM complex is 
directly affecting ADH2 expression. It is, however, possible that ADH2 expression is 
affected indirectly by spliceosomal defects. Improper splicing of a protein that is in some 
way responsible for the expression of ADH2 could result in suppression of the increased 
expression in sptlO cells.
A perhaps more compelling model for sptlO suppression in lsm6 strains involves 
its defects in RNA turnover. The decreased rate of mRNA turnover in lsm6 strains leads 
to an accumulation of mRNA. The abundance of low-tumover transcripts would not be 
expected to be affected as much as the mRNA abundance of high-tumover transcripts, 
which could be affected quite dramatically. Genes that are transcribed and degraded at 
high rates would accumulate mRNA more rapidly than those with low rates. The
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increased percentage of high rate mRNAs could outcompete slow rate mRNAs for 
ribosomes, leading to an imbalance of gene expression.
Since ADH2 mRNA is very stable and transcribed at a very low rate in these 
strains, any increases in ADH2 mRNA levels would be marginal. A high estimate of the 
number of molecules per cell of ADH2 mRNA in sptlO strains grown on glucose is five. 
The diluting out of ADH2 mRNA by other, normally high-tumover transcripts that are 
not being degraded in an lsm6 strain would be expected to decrease expression of ADH2 
sufficiently to allow growth on 10 mM allyl alcohol plates. An elaboration on this model 
is described later in the discussion.
ASG2/EBS1
ASG2 encodes a protein of 884 amino acids with a predicted size of 100 kDa. 
Asg2p is a basic protein with a predicted pi of 9.7. Since being identified in this screen, 
it has been named EBS1 in the Saccharomyces Genome Database based on sequence 
similarity to another gene, £577. EST1 is a subunit of the yeast telomerase and is 
required for the maintenance of telomere length. Mutations in ESTl result in telomere 
loss and senescence phenotypes [Zhou et al., 2000]. Analysis of the protein sequences 
showed 27% identity and 48% similarity between Estlp and Asg2p/Ebslp. While the 
function of Asg2p/Ebslp is unknown, it has been argued that it is also a telomerase based 
on sequence analysis.
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In an analysis done by Lundblad and Blackburn [1990], the ESTl sequence was 
aligned with a number of DNA and RNA polymerases. Four motifs were found 
containing five invariant residues, and 18 other highly conserved residues. This would 
indicate that these residues are important for polymerase function.
Using MegAlign of the DNA Star software package, ASG2 was aligned with 
EST1 for the purpose of determining if these residues are conserved in ASG2. Of the five 
invariant residues, only two were found to be identical in ASG2, and of the other 18 
highly conserved residues, only half were identical. The alignment also showed that over 
the complete sequences of these genes, the identical residues shared by ASG2 and ESTl 
were spread evenly along the length of the proteins, revealing no specific domains or 
motifs or any specific regions of significant identity. This would indicate that while 
ASG2 and ESTl share a significant amount of identity, it would not be reasonable to 
assume that ASG2 is necessarily a polymerase.
A different conserved motif shared by ASG2IEBS1 and E STl is the RNA 
Recognition Motif (RRM). Zhou et al. [2000] observed a "good match" between EBS1 
and a consensus RRM sequence, while the similarity of ESTl with the consensus 
sequence was not as good. Interestingly, the previously discussed polymerase domain 
and the RRM are overlapping in both genes. Since RNA binding is more dependent on 
overall protein structure than exact sequences, it is possible that ESTl had lost some of 
the similarity with the RRM in order to acquire polymerase function. Conversely, EBS1
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may have lost polymerase function to disuse, while retaining or even improving RNA 
binding ability.
In vivo studies of estl and ebsl strains showed that both genes are required for 
maximum telomere length. However, while estl strains have dramatically reduced 
telomeres, telomeres in ebsl strains are only slightly shorter. Interestingly, studies 
investigating the role of EST1 in the telomerase showed that neither EBSI nor ESTI was 
required for telomerase activity in vitro. It was also observed that ebsl mutants showed 
no senescence phenotype, although in an estl background a mild synthetic effect was 
observed [Zhou et al., 2000].
Based on this evidence, it appears that Asg2p/Ebslp plays only a minor role in 
telomere maintenance. It is possible that Asg2p/Ebslp may have a limited ability to 
complement estl due to their similarity, but no evidence exists that Asg2p/Ebs lp is a part 
of the yeast telomerase itself. Furthermore, the effects of an asg2 mutation on ADH2 and 
HIS3 in sptlO strains would in no obvious way be linked to telomere length. This 
suggests a second function for Asg2p/Ebslp.
In unpublished observations, Roy Parker has detected Ebslp in the DCP1 
containing complex responsible for mRNA decapping. Dcplp has been previously 
identified as the main decapping enzyme in yeast. Mutations in DCP1 result in the loss 
of the ability to decap mRNA, which results in the accumulation of oligoadenylated 
mRNAs. Interestingly, two classes of mutations have been observed in DCP1. Both
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classes affect the ability of Dcplp to decap mRNA in vivo, but one class retains its ability 
to decap mRNA in vitro, while the other does not. It has been proposed that one class of 
mutations directly affects the enzymatic ability of Dcplp to catalyze mRNA decapping, 
rendering it non-functional in vitro. The other class is believed to affect binding of other 
proteins that are required for regulated or efficient decapping in vivo.
Several lines of evidence point towards a functional role for Asg2p/Ebslp in 
mRNA degradation. Gbslp has been shown to interact with Dcplp in two-hybrid 
experiments, and it has been detected in the Dcplp complex. Asg2p/Ebslp contains an 
RRM motif thought to be involved in single stranded RNA binding, a function that would 
be consistent with a protein involved in decapping mRNA. Additionally, the same model 
proposed to explain the effects of an lsm6 mutation could account for the effects of an 
asg2 mutation. Finally, in light of the known functions of CCR4, CAF1, and 
ASG3/LSM6, screen performed seems to be generating mutations that affect mRNA 
degradation, and ASG2/EBS1 appears to be no different.
Two-hvbrid experiments and ASG2
Two hybrid experiments done with ASG2 have revealed three potentially 
significant interactions with the CCR4-NOT complex component Not2p, Asclp 
(involved in translation), and MptS (a Puf protein implicated in telomere maintenance 
and other processes). The interaction with Not2p may suggest that Asg2p may be
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interacting with the CCR4-N0T complex. While it has been shown that an asg2 
mutation does not affect the 1.0-1.2 MDa CCR4-NOT complex, it is possible that Asg2p 
is a component of the larger 1.9 MDa CCR4-NOT complex, but Asg2p also appears to 
interact with Asclp and Mpt5p, which are not. A discussion of the potential significance 
of the interaction with MptSp, which is believed to be involved in mRNA degradation, 
can be found later in the discussion. It should be noted, however, that the only proteins 
for which interactions with Asg2p were sought were proteins that have already been 
linked to CCR4 complex components by previous two hybrid experiments.
Genome-wide two-hybrid experiments have established that Asg2p/Ebslp can 
interact with Gal83p and Stdlp, both which are believed have roles in glucose repression, 
among other functions, as well as Dcplp, Mad2p and Mum2p [Uetz et al. 2000]. The 
significance of the interaction with Dcplp has already been discussed. The interactions 
with Mad2p, which is involved in cell cycle and mitosis, and Mum2p, which is involved 
in meiosis, are less easily understood. It is improbable that Asg2p/Ebslp is functionally 
interacting with all of the proteins listed above, further investigation is necessary to draw 
any conclusions based on the results of these experiments.
. Phenotypic Analysis
Unlike an allyl alcohol sensitivity phenotype, sensitivities to caffeine, 
temperature, and elevated salt concentration are general phenotypes. Sensitivity to allyl
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alcohol requires elevated ADH activity. Therefore, certain inferences can be made about 
allyl alcohol sensitive mutants that can be tested experimentally. Sensitivity to the other 
conditions tested are not necessarily due to any specific or well defined process, and are 
present in a wide variety of seemingly unrelated mutants.
Caffeine has pleiotropic effects on yeast cells, including inhibiting cAMP 
phosphodiesterase, DNA repair and DNA synthesis, as well as affecting cell wall 
integrity. Temperature sensitivity also results from a wide variety of defects. One 
specific defect that is better understood and particularly relevant to ccr4 mutations is cell 
wall integrity. 1 M sorbitol suppresses cell wall defects by osmotically stabilizing the 
cell. Significantly, the TS, CS, and caffeine phenotypes of ccr4 strains are all suppressed 
by 1M sorbitol.
Cell Wall Integrity
Protein kinase C in yeast (Pkclp) has been shown to be critical for cell wall 
integrity, and the known components of the MAP kinase pathway under Pkclp control 
(Bkclp, Mkkl-2p, Mpklp) are all involved in this process (Paravicini et al., 1992; Levin 
and Errede, 1995]. Typical of mutations affecting the cell wall, defects in mating and 
osmoregulation were also observed in mutations of many of these genes.
Mutations in PKCl have been shown to affect the expression of genes involved in 
cell wall biosynthesis, but the targeted transcription factors are not known. A link,
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however, between Pkclp and the Paflp holoenzyme has been recently described [Chang 
et al., 1999]. Swi4p is also involved in cell wall maintenance, but by a different 
mechanism than Pkclp [Igual et al., 1996]. Thus, cell wall integrity is controlled by 
multiple mechanisms.
As for the role of Ccr4p in cell wall integrity, ccr4 strains show reduced 
expression of KRE6 (putative beta-l,6-glucan synthase subunit) and VAN2 (Golgi GDP- 
mannose transporter), two genes involved directly in cell wall biogenesis [Roemer et al., 
1994; Kanik-Ennulat et al., 1995]. In a different study, a ccr4 mutation was shown to 
affect the expression levels of 161 genes. A ccr4 mutation elevates expression levels of 
ten genes involved in cell wall integrity, while reducing the levels of three genes. The 
current model proposes that this effect on expression of cell wall genes disturbs a balance 
of cell wall components, resulting in cell wall defects.
Clearly, cell wall integrity is a major function of CCR4, as nearly ten percent of 
all genes whose expression is affected by ccr4 are cell wall genes. Whether Ccr4p acts as 
a target of Pkclp or by a separate mechanism is not known. However, with the 
identification of an interaction between Ccr4p and the Paflp holoenzyme, a possible 
target of the Pkclp-MAP kinase pathway, is evidence in support of a link between Pkclp 
and CCR4.
None of the phenotypes of the revertants studied in this work were suppressed by 
1 M sorbitol, and, therefore, do not appear to be involved in cell wall integrity. The
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effects of ccr4 on cell wall integrity seem to be indirect. Another phenotype present in 
some of the revertants is lithium sensitivity. It is in this work that lithium sensitivity of 
ccr4 mutants was first observed, and some possible mechanisms by which it occurs are 
presented below.
Lithium Sensitivity
Suppression of Methionine axuotrophy in cpfl strains by ccr4 mutants indicates a 
role for Ccr4p in Methionine biosynthesis [McKenzie et al., 1993]. Interestingly, a study 
by Dichtl et. al. [1997] on HAL2IMET22 has linked Methionine metabolism with RNA 
processing and lithium sensitivity. Hal2p catalyzes the breakdown of adenosine 3',5' 
bisphosphate (pAp) resulting from the sulfate assimilation pathway, preventing pAp 
accumulation, which inhibits exoribonucleases Ratlp and Xml p. Biochemical studies 
showed that the effects of lithium, which inhibits Ha!2p, on wild type cells mimics the 
hal2 phenotype, both of which could be totally suppressed by the presence of 
Methionine. While the lithium sensitivity of ccr4 mutants could be due to improper 
regulation of Methionine metabolism, the recent discoveries that revealed that Ccr4p is 
involved directly with mRNA deadenylation suggest another mechanism.
CCR4 and C AF l have been shown to encode deadenylase components. 
Mutations in either gene results in incomplete deadenylation and reduced mRNA 
turnover. Additionally, HAL2 expression is reduced 3-4 fold in ccr4 strains, which could
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mimic the hal2 phenotype described above. This couid result in Xmlp inhibition similar 
to that found in hal2 strains, where pAp accumulation inhibits Xmlp. The ccr4 mutation 
may also be affecting Methionine metabolism indirectly, and the resulting effects could 
also be contributing to the end result of lithium sensitivity as described in Dichtl et al.
[1997].
Concluding Remarks
When the work described above was initiated, CCR4 and CAFl were the only two 
known suppressors of sptlO. Subsequent research identified other suppressors of sptlO, 
all of which played an important role in ADH2 expression. Nevertheless, CCR4 was the 
only gene identified in a screen for sptlO suppression. The genes identified in this screen 
prove that there are a number of additional genes with the ability to suppress sptlO that 
are also required for maximal expression of ADH2. These genes appear to be affecting 
expression at nearly all points in what could be termed the "life cycle" of mRNA, which 
is presented in Figure 4.1.
CCR4 and CAFl are known to be required at transcriptional initiation, but also 
have a role as components o f yeast deadenylase. ASG3/LSM6 is involved in RNA 
processing by its association with spliceosomal snRNAs. It is also required for 
decapping, and it appears likely that ASG2IEBS1 is also involved at this step. Finally, 
ASG6/NUP159 is required for mRNA export to the cytoplasm.
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Figure 4.1: Genes Affecting Multiple Points in the mRNA "Life Cycle".
The mRNA is shown here with highly schematized caps and poly-A tails, "nuc" means 
located in the nucleus, "cyt" means located in the cytoplasm.
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Regulation of Degradation
The fact that all of the genes identified in this screen affect points in the pathway 
shown in Figure 4.1 is an interesting one. More interestingly, perhaps, is the fact that it is 
this particular pathway. Gene expression in yeast is thought to be regulated primarily at 
the point of transcriptional initiation, with additional regulatory points at transcriptional 
elongation and translation. Certainly the degradation of transcripts is important in the 
complete picture of gene regulation, especially for the removal of mRNAs to efficiently 
adapt to environmental change. Intuitively, however, one would expect this screen to 
produce mutations in genes that are responsible for ADH2 expression at all important 
regulatory points, not just ones involved in degradation.
Possible explanations for these observations are that ADH2 is simply not 
regulated at the translational or transcriptional elongation levels, or that it is and the 
remaining unidentified revertants that were produced by this screen are mutations in such 
regulatory genes. While this may, to a certain degree, be true, I believe that the best 
answer is directly related to the nature of ADH2 itself. As a gluconeogenic gene, its 
expression is very tightly regulated. Mutations in genes such as MIG I, TUP I, and CYC8, 
which relieve repression form numerous promoters, have no effect on ADH2. SPT10 is 
unusual in that it does, and for the same reason, the nature of the function of any gene 
that is able to suppress this effect must be correspondingly exceptional. The known 
suppressors of sptlO atADH2 that were identified independently of my screen are all a
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part of the CCR4-NOT complex, which is known to be essential to ADH2 expression. 
Even these genes are a minority subset of all of the components of this complex. The 
only exceptions are SRB9 and SRBIO which are not associated with the CCR4-NOT 
complex, but are components of the RNA Polymerase n  holoenzyme, the very engine 
that enzymatically drives transcription. Only mutations in genes that are so essential to 
the transcription of ADH2 are capable of altering the tight regulation of ADH2 expression 
at transcription.
I believe that this screen has revealed another class of mutations that are capable 
of affecting ADH2 expression, albeit by less direct means. The previously described 
genes were for the most part discovered by direct or indirect physical interactions with 
CCR4. Despite my efforts to produce CCR4-like genes while relaxing the stringency of 
the screen, the genes identified do not appear to be CCR4-NOT components, nor do they 
appear to be transcription factors. What mutations in these genes do, however, is 
significantly alter the process of degradation. Such a breakdown could render many 
regulatory mechanisms ineffective, either by preventing their action or overwhelming 
their expression with misregulation of other genes. It is likely that any effects of 
comparable severity to, for instance, the translation process would render the yeast 
inviable, and, therefore, would not be produced by this screen. Since a breakdown in 
mRNA degradation is less likely to limit the production of essential proteins, it is less 
likely to result in inviability and would survive the screening process.
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Factors Influencing the Degradation Model of Altered ADH2 Expression
Previously, I proposed a model to account for the reduced expression of ADH2 in 
lsm6 and ebsl strains. A breakdown in degradation pathways resulting in accumulation 
of oligoadenylated mRNAs could result in reduced ADH2 expression. This is due to the 
fact the stable mRNAs transcribed at low rates would accumulate less rapidly than high 
turnover mRNAs transcribed at high rates. The resulting effect is a diluting out of stable 
mRNAs, reducing their relative concentration and, therefore, their expression. In these 
strains, the degradation defect would also affect the cells ability to adapt to environmental 
change, as mRNA degradation is a critical step in the stress response. In this manner, the 
model also provides an explanation for the sensitivities to caffeine, temperature, and 
elevated salt concentration observed in these revertants. Figure 4.2 presents this model 
pictorially.
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Stable mRNAs Unstable mRNAs
transcribed at transcribed at
low rates high rates
Reduced degradation in asg strains, 
resulting in accumulation of 
oligoadenylated mRNAs
Minimal Potentially dramatic
accumulation of accumulation of
mRNA, if any mRNA
Figure 4.2: A Model for sptlO Suppression.
In asg mutant strains, the accumulation of oligoadenylated mRNAs would occur much 
more rapidly in high turnover transcripts, as shown on the right. The result is a reduced 
relative concentration of stable, low turnover transcripts like ADH2. This could result in 
ADH2 mRNAs being outcompeted for ribosomes, thereby reducing ADH2 expression. 
Other factors that may be affecting this model are discussed in the text.
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This model assumes that there are a limiting number of ribosomes in the cell, 
which restricts the number of transcripts that ribosomes can translate. There are 
approximately 15,000 molecules of mRNA per yeast cell, and the number of protein 
molecules synthesized per mRNA has been estimated at up to 4000 [Hereford et al., 
1977, Futcher et al., 1999]. Accordingly, the number of ribosomes per cell is huge, 
estimated to be on the order of hundreds of thousands of per cell when grown on glucose 
at 30°C. Astonishingly, ribosomes account for fifty percent of the dry weight of a 
dividing yeast cell. Some admittedly primitive calculations support, at least in theory, 
that ribosome number is at least in rough agreement with a hypothesis that ribosomes 
translate mRNAs indiscriminately, but certainly room is left for posttranscriptionai 
regulation. One important feature, however, is the fact that ribosomal gene expression is 
highly sensitive to nutritional and environmental factors. For example, yeast growing at 
23°C and 36°C have roughly the same number of ribosomes. However, yeast shifted 
from 23°C to 36°C undergo a dramatic reduction in ribosomal gene expression, followed 
by degradation of ribosomal proteins and transcripts. This is followed by reestablished 
transcription of ribosomal genes and ribosome production to the previous levels. The 
number of ribosomes per cell, however, is less at 23°C and 36°C than it is at 30°C. 
Ribosomal genes are very well regulated and are expressed at roughly equimolar amounts 
[Broach et al., 1991].
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The number of ribosomes per cell is also dependent of other factors. It is known 
that a ccr4 mutation in ethanol grown cells dramatically reduces the expression of a 
subset of ribosomal genes. This necessarily results in reduced numbers of ribosomes. 
Ribosome assembly is a highly cooperative process, and excess ribosomal proteins are 
quickly degraded. This same effect may be occurring in asg2 and asg3 strains, reducing 
the number of available ribosomes, which could result in competition among mRNAs for 
ribosomes, making their relative concentrations an important factor in their expression.
Another factor that could be affecting gene expression in asg2 and asg3 strains 
specifically involves defects in decapping. It is widely accepted that initiation of 
translation mainly occurs by ribosomal recognition of the mRNA cap, followed by 
sliding down the 5' nontranslated region until an AUG codon is located, at which time 
protein synthesis commences. Therefore, recognition and subsequent binding of the 
mRNA cap by the ribosome is a fundamental step in gene expression. It is possible that 
the lack of a single protein that is necessary for the proper regulation of the decapping 
complex may only inhibit the cleavage step, but not the recognition step. The result is 
that in such a strain that is deficient for decapping, the nonfunctional decapping complex 
may still be able to bind the mRNA cap. This could inhibit mRNA cap recognition by 
ribosomes, resulting in globally reduced protein synthesis.
Lastly, oligoadenylated mRNAs are less efficiently translated than fully 
polyadenylated mRNAs. The expression of accumulating oligoadenylated mRNAs,
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therefore, may be reduced due to this lack of translation efficiency. This effect could also 
prevent global ribosomal function by occupying ribosomes in unsuccessful translation 
initiation events.
All of these factors could be contributing to the reduced expression of ADH2. It 
is, however, possible that these defects are affecting the expression of other genes that are 
necessary for proper ADH2 expression.
The Nature of Regulation
One final issue worth discussing is the nature of regulation itself. It is worthwhile 
to consider whether the genes identified in this screen are specifically involved in 
regulation of ADH2 expression, or are simply factors that are required for basic processes 
of the cell that affect transcripts globally. It is the nature of a genetic screens to produce 
both types of mutations, and in reality, most of the time the answer is somewhere in 
between.
To elaborate, consider the fact that RNA Polymerase II (Pol II) is required for 
transcription of all mRNA genes. Therefore, it is not involved in regulation itself, 
although other regulatory proteins must go through it to perform their function. A host of 
other proteins are associated with Pol H, many are likewise required indiscriminately at 
all promoters. For a protein to have regulatory function it must not be required for the 
expression of at least one gene, and every gene cannot have its own set of transcriptional
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regulatory proteins. Even specific sequences in a gene's promoter that recruit specific 
proteins that bind them are often found in multiple promoters. Regulatory processes 
observed at a single gene are very likely occurring to a set of genes, probably related in 
some way, possibly not.
The situation is, of course, more complex than this. Pol n  is an enzyme and its 
evolved structure is not solely dictated by how efficient it is as a polymerase, but also its 
ability to make the contacts with other proteins in such a way to facilitate a fully 
regulated transcriptional system that is most advantageous to the cell. However, it is 
useful to consider these points when contemplating the function of the proposed 
regulatory proteins generated by this screen.
ASG6/NUPI59 is an essential gene that encodes a nuclear pore complex 
component, which is responsible for the export of all mRNAs to the cytoplasm. I would 
argue that it is unlikely that ASG6/NUP159 plays any direct role in regulating the export 
of ADH2 mRNA. Like mutations in ADH2 itself, mutations in ASG6/NUP159 fulfilled 
the requirements that expression of ADH2 be lowered to a level to allow growth in the 
presence of allyl alcohol. For ASG2IEBS1 and ASG3/LSM6, the situation is different. 
DCPl with its interaction with ASG2/EBSI as well as the ASG3/LSM6 containing 
cytoplasmic LSM complex are both involved in the mRNA decapping step. Both genes 
appear to be associated with the process in a regulatory fashion. An lsm6 mutation 
results in inefficient decapping, although DCPl, the decapping enzyme, is physically
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unaffected. Experiments have shown that some mutations in DCPl that do not affect its 
ability to decap mRNAs in vitro are defective for decapping in vivo. This suggests that 
DCPl contacts other proteins in the context of the decapping complex that have the 
ability to affect decapping, very likely in a regulated fashion. Mutations in ASG2/EBS1 
and ASG3/LSM6 may simply be blocking degradation nonspecifically, accidentally 
leading to the misregulation of ADH2. Further experimentation is necessary to resolve 
this.
The two-hybrid interaction between Asg2p and MptSp may reveal a means of the 
regulatory function of Asg2p. MptSp was recently found to contain a Puf domain, a 
conserved eight repeat motif that can bind RNA in a sequence dependent manner. Puf 
proteins were originally identified in C. elegans and Drosophila, where they regulate 
expression by repressing translation and stimulating mRNA turnover. This is of 
particular importance in the developmental processes of these organisms, as maternally 
inherited transcripts are necessary for proper development and their expression must 
necessarily occur posttranscriptionally. hi yeast, development is not an issue, but rapidly 
dividing yeast cells may use similar mechanisms in stress response pathways. Efficient 
removal of proteins and transcripts is necessary for effective stress response. Given the 
temperature and Lithium sensitivities of an asg2 strain, Asg2p may be involved in the 
degradation pathways of the stress response.
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Clearly, regulation of gene expression occurs at many steps, from transcription to 
degradation to translation. With the discovery that CCR4 and CAFl are involved in 
mRNA degradation, a new era in CCR4 research has begun. The results of this work will 
provide new and relevant avenues for further investigation into CCR4 function and the 
complete regulation of ADH2 expression.
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